Understanding the relationship between positive affect and cortisol in lung cancer patients. by Zimmaro, Lauren Ann
University of Louisville 
ThinkIR: The University of Louisville's Institutional Repository 
Electronic Theses and Dissertations 
8-2018 
Understanding the relationship between positive affect and 
cortisol in lung cancer patients. 
Lauren Ann Zimmaro 
University of Louisville 
Follow this and additional works at: https://ir.library.louisville.edu/etd 
 Part of the Clinical Psychology Commons, and the Health Psychology Commons 
Recommended Citation 
Zimmaro, Lauren Ann, "Understanding the relationship between positive affect and cortisol in lung cancer 
patients." (2018). Electronic Theses and Dissertations. Paper 3047. 
https://doi.org/10.18297/etd/3047 
This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's 
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized 
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the 
author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu. 
    
 
UNDERSTANDING THE RELATIONSHIP BETWEEN 





Lauren Ann Zimmaro 
B.A., Wake Forest University, 2010 






Submitted to the Faculty of the  
College of Arts and Sciences of the University of Louisville 
in Partial Fulfillment of the Requirements 




Doctor of Philosophy 
in Clinical Psychology 
 
 
Department of Psychological and Brain Sciences 































    
 ii	  
 
UNDERSTANDING THE RELATIONSHIP BETWEEN 




Lauren A. Zimmaro 
B.A., Wake Forest University, 2010 
M.A., University of Louisville, 2015 
 
A Dissertation Approved on 
 
May 15, 2018 
 
 

























Elizabeth Cash, PhD 
    
 iii	  
DEDICATION 
This dissertation is dedicated to 
the lung cancer patients and their families 


















    
 iv	  
ACKNOWLEGMENTS 
I would like to extend my deepest gratitude to Sandra Sephton, PhD for her 
unwavering support and mentorship, not only throughout this dissertation, but also 
through the entirety of my graduate training. She has been an inspiring example of 
scientific passion and intellectual curiosity. This dissertation would not have been 
possible without her kindness, motivation, and leadership over the past five years.   
I would also like to thank my dissertation committee members, Liz Cash, PhD, 
Janet Woodruff-Borden, PhD, Paul Salmon, PhD, Ben Mast, PhD, and Tamara Newton, 
PhD, for their support, time, and dedication to helping with this current work. I am 
grateful for their commitment to being teachers and leaders in psychology.  
Thank you as well to the amazing Biobehavioral Research lab members who were 
a foundation to this research, especially Kala Phillips, M.S. and Chelsea Siwik, M.S., 
who were crucial to recruitment, data management, and overall support throughout the 
entirety of the study. Thank you to Christy Albert and Whitney Rebholz, PhD for their 
enthusiasm and countless hours in the wet lab, and to Rene Bayley-Veloso, Ph.D. for her 
assistance in data management. Thank you to the dedicated team of undergraduate 
research assistants for their time and energy:  Natalie Vitalis, Jenna Wilbur, Steven Hall, 
Matthew Lyons, Olivia Fields, and Madeline Hudson. Last, thank you to the medical staff 
at James Graham Brown Cancer center for assisting in the recruitment and patient 
referrals for this current research. 
  
    
 	  	  v
 To my family – Mom, Dad, Lindsey, and Mike – thank you for helping me stay 
motivated and grounded during this journey.  This road would not have been possible 
without you, and I am indebted to your unwavering support and love. To my friends near 
and far, thank you for keeping me laughing and balanced throughout graduate school. I 





















UNDERSTANDING THE RELATIONSHIP BETWEEN POSITIVE AFFECT AND 
CORTISOL IN LUNG CANCER PATIENTS 
Lauren A. Zimmaro 
May 15, 2018 
 Positive psychobiological processes within lung cancer patients are drastically 
understudied. This dissertation explores the nature of positive affect (PA) and potential 
associations with diurnal cortisol among lung cancer patients, given the prognostic 
significance of diurnal cortisol rhythms. Theoretical underpinnings and current literature 
involving PA, cancer, and diurnal cortisol are first reviewed. An original integrated 
model of PA and cortisol among cancer patients is then presented, from which the 
proposed dissertation study and analyses are derived. 
 Sixty-one non-small cell lung cancer patients provided self-report assessment of 
mood (PANAS PA and NA subscales, CES-D PA subscale), medical and demographic 
characteristics, and 10-day salivary cortisol. Aim 1 tested hypotheses that: (1) patients 
will experience moderate PA, and more PA than NA, (2) PA and NA will emerge as 
separate factors in factor analyses, and (3) higher PA will correlate with variables 
reflecting lower disease burden.  Aim 1 was assessed through descriptive statistics, 
correlations, t-tests, and exploratory factor analyses. Aim 2 tested hypotheses that: (1) 
higher PA will relate to lower cortisol means, (2) higher PA will relate to steeper diurnal 
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slope, (3) PA will relate more strongly to overall mean cortisol than diurnal slope.  Aim 2 
was tested through hierarchical linear regressions and path analyses.  
 Aim 1 results showed that patients generally held positive emotions and endorsed 
PA items that reflected determination and resilience. They also reported more PA than 
NA; these two constructs emerged as separate and distinct factors.  Race, smoking, and 
current treatment all significantly related to PA.  Aim 2 revealed that PA did not 
significantly associate with mean cortisol variables or diurnal slope. However, higher NA 
was associated with flattened slopes, after excluding patients taking corticosteroids. 
Although the relationship between PA and mean cortisol was consistently stronger than 
with diurnal slope in path analyses, the associations were non-significant.  
 Patients reported experiencing positive emotions that may reflect resilience and 
adaptive coping. Positive affect did not have strong associations with cortisol, which may 
be due to pre-existing cortisol dysregulation or small sample size. Future studies should 
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The field of psychology is in the midst of a paradigm shift. For decades, the focus 
of research, clinical work, and policy has been on the identification and treatment of 
psychopathology. In recent years, however, attention has moved towards the other end of 
the spectrum—human flourishing. This study of “positive psychology” seeks to 
understand the benefits of positive emotions on mental and physical health (Seligman & 
Csikszentmihalyi, 2000). Indeed, evidence of health benefits associated with positive 
psychological processes is mounting (e.g., Pressman & Cohen, 2005). In healthy samples, 
positive affect has been shown to independently associate with healthier physiological 
processes of neuroendocrine, autonomic, and immune systems (Dockray & Steptoe, 
2010).  What is notably lacking, however, is a particular focus on physiological 
mechanisms. Given the present evidence, this line of inquiry may have important 
relevance to processes in medical disorders, yet there is a particular paucity of research in 
how positive emotions relate to physiological processes in people with serious illness, 
such as cancer.  
The historical context surrounding the topic of positive psychology and cancer 
outcomes is an emotionally charged one.  The associations between positive 
psychological constructs and cancer progression have typically either been 
overemphasized or underemphasized, with extremes lending themselves to producing 
patients’ unreal expectations of healing and/or guilt and burden. Given the vast advances 
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in cancer research, a new and integrative scientific approach to this topic within the field 
is both timely and necessary. Improvements in cancer treatments and outcomes shift the 
focus of disease models towards those of survivorship, away from merely increasing 
quantity of life to those of increasing quality of life. As such, understanding the link 
between biology and positive emotional processes in cancer patients helps strengthen the 
bridge between disease and survivorship models.  
Positive Affect  
One of the basic areas of research in positive psychology is that of positive affect 
(PA). Positive affect is the subjective experience of positive moods, like joy and 
happiness, stemming from pleasurable engagement with one’s environment (Clark, 
Watson, & Leeka, 1989; Pressman & Cohen, 2005). These feelings may be momentary, 
longer lasting, or even seemingly dispositional (Pressman & Cohen, 2005). Shorter-term 
PA is referred to as “state PA” (such as joy, happiness, or pleasure) while longer-lasting 
positive affect is referred to as “trait PA” (Pressman & Cohen, 2005). However, this 
distinction is not always clear, and trait PA may not necessarily be best represented by an 
aggregate score of state PA, as seen in some research. Instead, recent research has 
highlighted the importance of considering affect variability as an indicator of mental 
health (Houben et al., 2015). For both PA and NA, low variability (within-persons 
standard deviation from momentary mean affect) and high stability (low change from 
moment-to-moment) is associated with higher psychological well-being (Houben et al., 
2015). This distinction may be particularly important in the cancer context, as moods 
may shift and reflect varying emotional demands throughout the cancer journey.  
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Historically, affective valence – the degree to which emotions are considered 
positive or negative – was considered bipolar, where PA was merely the opposite of 
negative affect (Wundt, 1897/1998). However, as research progressed, an alternative 
view of bivalence was put forth. The bivalence hypothesis follows the data supporting 
that PA and negative affect (NA) are often uncorrelated and thus may be independent 
constructs (e.g., Watson, Clark, & Tellegen, 1988). This view was furthered by research 
supporting that PA and NA may be grounded in distinct biological systems (Cacioppo, 
Gardner, & Bernston, 1999; Diener & Emmons, 1984; Diener, Smith, & Fujita, 1995; 
Norris et al., 2010). As such, the presence of PA, rather than the absence of NA, deserves 
unique attention.  
Affect may be also described based on the dimension of arousal. The affective 
circumplex model describes how emotions may be categorized based upon 
multidimensional circumplex anchored by these two perpendicular scales (valence and 
arousal; Russell, 1980). For example, a high arousal PA may be “excitement”, while low 
arousal PA may be “relaxed.” A nuanced approach to understanding PA in regard to 
arousal may have particular relevance as it relates to the body’s stress response; however, 
the role of emotional arousal is typically underemphasized in mind-body research.  
Researchers commonly note the lack of consensus in defining or referring to PA 
(e.g., Pressman & Cohen, 2005; Dockray & Steptoe, 2010). From a historical and 
philosophical perspective, PA has been categorized within two realms: hedonia and 
eudaimonia.  The first concept, hedonia, typically refers to the experience of state and/or 
trait PA, with the absence of NA (Ryan & Deci, 2001). Hedonia also includes “subjective 
well-being” (SWB) — the global tendency to experience more positive than negative 
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affect, as well as judging one’s life as satisfactory (Deci & Ryan, 2008; Diener, 2000; 
Howell, Kern, & Lyubomirsky, 2007). The second concept, eudaimonia, refers to overall 
psychological well-being (PWB; Ryff, 1989), which includes experiences of PA, but 
focuses more on living a full life of meaning and growth (Deci & Ryan, 2008; Ryff, 
1989). Research supports that hedonia and eudaimonia are separate but related constructs 
(Davis et al., 2015; Fredrickson et al., 2013; Keyes, Shmotkin, & Ryff, 2002; Ryff et al., 
2006; Ryff et al., 2004; Waterman, 1993). In research however, the terms referring to PA 
and well-being tend to be used interchangeably, contributing to difficulty in 
understanding how these factors may individually relate to physiology. An important 
qualitative distinction may be made between the two concepts in how they relate to a 
flourishing life: hedonia may be considered an endpoint or “result”, while eudaimonia 
may be conceptualized as the “process” or “content” (Seligman, 2004).  
Barbara Fredrickson (2001) proposes that PA and broader experiences of 
psychological well-being are related through a “broaden and build” process.  The 
Broaden and Build Theory suggests that positive emotions are not just markers of well-
being, but in fact produce it. In particular, momentary PA encourages thought broadening 
(such as awareness and creativity) and approach behaviors (like play and exploration). 
These momentary experiences help people to build physical, social, intellectual, and 
emotional resources, which together create psychological resources. These psychological 
resources are similar to the eudaimonic well-being described by Ryff (1989). 
Experiencing these diverse set of resources feeds back to create more positive emotions. 
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Cancer 
 It is difficult to find a person who has not been touched by cancer in some way in 
the modern age. High incidence and mortality rates, steep costs of treatment, and physical 
and emotional suffering of both patients and their social networks make cancer an area of 
prominent scientific, political, and social investment.  Cancer refers to a collection of 
diseases all characterized by the uncontrolled dividing and spreading of cells in the body 
(National Cancer Institute, n.d.) and is the second leading cause of death in the United 
States (Centers for Disease Control, 2016). The complex features of tumor cells are 
characterized into six “hallmark capabilities”: sustaining proliferative signaling, evading 
growth suppressors, resisting cell death, enabling replicative immortality, inducing 
angiogenesis, and activating invasion and metastasis (Hanahan & Weinberg, 2011). 
Cancer initiation and progression is the result of multiple factors such as genetics, 
immune and endocrine function, and lifestyle (Bissell & Hines, 2011). However, the 
multifaceted nature of cancer extends to psychology, including the role of stress biology, 
as well as the individual psychological and emotional experience of the cancer journey.  
Given its implications for public health, science continues to forge forward in efforts to 
understand both the biology and psychology of cancer. 
Lung cancer. Lung cancer is the most commonly diagnosed cancer and the 
leading cause of cancer related death among men and women worldwide (Centers for 
Disease Control, 2015). Prognosis among non-small cell lung cancer patients is poor. 
Five-year survival rates among early stage non-small cell lung cancer patients range from 
about 53 – 92% (stage I: 68 – 92%, stage II: 53 - 60%; American Cancer Society, 2017); 
however, many patients are not diagnosed until advanced stages, when the disease has 
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already spread and become symptomatic (American Cancer Society, 2017). Prognosis 
among late stage patients is much lower, with 5-year survival rates for stage III ranging 
from 13-26% and stage IV ranging from 1-10% (American Cancer Society, 2017). 
Lung cancer is met with greater distress than most other cancers (Brintzenhofe-
Szoc et al., 2009; Linden et al., 2012; Zabora, BrintzenhofeSzoc, Curbow, Hooker, & 
Piantadosi, 2001). Patients with lung cancer experience a high symptom burden and 
symptom distress, even among those who are high-functioning (Temel, Pirl, & Lynch, 
2006). The most common symptoms reported include fatigue, shortness of breath, lack of 
energy, and cough. Only a minority of patients respond to treatment, thus many still 
endure tumor growth throughout their illness (Temel et al., 2006). Furthermore, treatment 
side effects may outweigh any relief associated with disease improvement, leaving many 
patients with little clinical or quality of life improvement (Temel et al., 2006).  
The emotional burden of a lung cancer diagnosis is unique from other cancers. 
Given the well-known link between smoking and cancer, the impact of stigma 
surrounding a diagnosis often brings emotions of guilt and shame and is associated with 
poorer quality of life and higher psychological distress  (Chambers et al., 2012). The 
compounding physical, emotional, and social burden of lung cancer is associated with 
patient depression (Graves et al., 2007). As with other cancers, major depressive disorder 
predicts worse survival among lung cancer patients (Pirl et al., 2012).  
The coupling of poor prognosis and painful physical symptoms (e.g., shortness of 
breath, chest pain, coughing up blood, weakness) make lung cancer particularly 
disturbing to a patient. These patients face a difficult path of treatment, recovery, and 
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physical symptoms, all in the context of potentially being at end-of-life in only a few 
short years or months.    
Positive Affect and Cancer 
In the face of poor prognosis as well as physical and emotional disease-burden, it 
may seem that experiences of joy, excitement, contentment, and other positive emotions 
may be infrequent among lung cancer patients. To date, there is very little research on the 
experience of positive emotions in this vulnerable population. Some of this literature 
exists among samples of other cancer types; however, the paucity of research in this area 
is notable (Louro, Fernández-Castro, & Blasco, 2015).  One study found that advanced 
cancer patients overall experienced more PA than NA on the PANAS; although, the 
overall levels of PA were slightly lower than in the general population (Voogt et al., 
2005). In a recent review, PANAS scores across several cancer types indicated that 
patients on average experienced low NA and moderate PA (Louro et al., 2015). Positive 
affect in cancer patients seems to be associated with better general health, better social 
functioning, benefit finding, low depression and anxiety (Louro et al., 2015). The review 
also noted that many studies show that changes in PA are greater predictors of quality of 
life and illness adaption than changes in NA (Louro et al., 2015).  
Studies on the role of demographic and medical factors show mixed results, 
perhaps due to the heterogeneity of cancer types and other sample factors. The role of 
cancer stage or treatment factors could not be established from the available literature 
(Louro et al., 2015). However, in a sample of 105 mixed-cancer patients, authors found 
that older, male, lower income patients for whom surgery was planned experienced less 
positive feelings than patients of other demographics (Voogt et al., 2005). Advanced 
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cancer stage has been shown to correlate with lower PA, but not with eudaimonic well-
being (Davis et al., 2015). These findings highlight that medical and demographic 
variables may play a role in the experience of positive emotions; however, more research 
is needed in this area, and especially within lung cancer patients.  
Positive affect in cancer patients may also relate to physical, cognitive, and social 
factors.  Lower PA has been shown to associate with higher fatigue; and lower physical, 
cognitive, and role functioning (Voogt et al., 2005). In the same study, the researchers 
found that higher PA was associated with more social support and problem-focused 
coping. Patients reporting higher PA experienced more meaning, peace, and perceived a 
role of faith, even after controlling for demographics, coping, and symptoms. The authors 
suggested that low PA may be driving distress (rather than the presence of high NA as in 
psychiatric depression and anxiety) as the cancer sample showed lower PA, but similar 
levels of NA, than the general population (Voogt et al., 2015).  Another study drew 
similar conclusions, after finding a loss of PA from diagnosis to three-month follow-up 
was associated with greater mood disturbances (Hou, Law, & Fu, 2010).  
Among cancer survivors, some research indicates that elements of well-being are 
similar to that of healthy populations (Bradley, Rose, Lutgendorf, Costanzo, & Anderson, 
2006; Helgeson & Tomich, 2005), including psychological and social well-being  
(Costanzo, Ryff, & Singer, 2009). Although survivors may experience more distress than 
those who have never been diagnosed with cancer (Rabin et al., 2007), PA may increase 
with time since diagnosis (Costanzo, Stawski, Ryff, Coe, & Almeida, 2012). One study 
showed that when survivors experienced daily stress, they demonstrated less pronounced 
declines in PA than healthy control, which may demonstrate resilience (Costanzo et al., 
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2012).  Together, the relationship between PA and time since diagnosis may suggest a 
process of coping and resilience. 
Other research suggests that feelings of joy, inner peace, and happiness are 
associated with increased quality of life in patients, with joy specifically being associated 
with having a more meaningful life and a good death (Lin & Bauer-Wu, 2003). Other 
studies suggest that patients with positive affect also experience more meaning, peace, 
and perceived role of faith (Voogt et al., 2005). Among lung cancer patients, the ability to 
maintain some level of positive emotion may be a similar sign of resilience and adaptive 
coping, such as through meaning-making and acceptance. 
Cortisol  
 The role of the stress response and the hypothalamic-pituitary-adrenal (HPA) 
pathway in tumor progression has become an area of significant focus in the field of 
psycho-oncology. In the face of stress, the human body responds to a perceived threat via 
two coordinating systems (Chrousos, 1998; McEwen, 1998). The first response is 
conducted by the autonomic nervous system: rapid sympathetic nervous system 
activation modulates responses such as increased heart rate and breathing, and reducing 
digestion. The slower second system is the HPA axis, which has basal circadian rhythm. 
The HPA response involves the integration of central nervous system components 
including cortical and limbic structures, as well as blood borne signals such as hormones 
and cytokines (Chrousos, 1998). When the body perceives a stressor, the HPA axis 
activates a cascade of physiological processes, culminating in the release of 
glucocorticoids including cortisol. Cortisol may be detected in blood, saliva, and urine; 
however, the levels of detectable hormone differ between these fluids (Hellhammer, 
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Wüst, & Kudielka, 2009). Cortisol is involved in a host of biological systems and 
processes including the central nervous system (e.g., learning, memory, and emotion; 
blood pressure, cardiovascular function), metabolic processes (e.g., glucose utilization), 
and immune responses (e.g., regulating inflammatory responses; Sapolsky, Romero, & 
Munck, 2000). Importantly, cortisol also plays a key feedback role in ending the stress 
response, by acting on receptors in the hippocampus, frontal cortex, hypothalamus, and 
anterior pituitary gland (Chrousos, 1998; Chrousos & Gold, 1992). 
Salivary cortisol provides a relatively simple and reliable measure of human stress 
responses, particularly in ambulatory studies, and thus is a widely used measure in 
psychoneuroendocrinology (Kirschbaum & Hellhammer, 1994). In comparison to 
sympathetic responses such as heart rate or blood pressure, cortisol may easily provide 
data regarding external and endogenous stress reactivity data as well as longitudinal 
rhythms. The HPA stress response may be measured by acute cortisol secretion after a 
stressor or cortisol secretion over the day. Summary measurements may include area 
under the curve (AUC) for overall secretion over time or a score such as the mean 
cortisol value measured from several collection points throughout the day. 
Diurnal rhythms. Cortisol follows a circadian rhythm. Levels are low in the 
evening and throughout night, but rise in the morning before waking. As a proxy measure 
of this rhythm, a diurnal rhythm may be estimated by calculating the slope between the 
waking and evening levels of cortisol as measured by multiple salivary samples (e.g., 
Sephton, Sapolsky, Kraemer, & Spiegel, 2000). Diurnal slope is an indicator of strength 
of HPA rhythmicity (Kraemer et al., 2006).   
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 A second phenomenon of cortisol, known as the cortisol awakening response 
(CAR), is the spike of cortisol secretion that occurs upon awakening and continues to rise 
to a peak level about 20-45 minutes later (Chida & Steptoe, 2009; Pruessner et al., 1997). 
The most common metrics of CAR are the mean difference in waking and peak morning 
values and the slope of the increase (Chida & Steptoe, 2009). CAR is commonly used in 
research to provide a unique measure of HPA activity, sparked endogenously by the 
behavior of awakening, that is partially independent from cortisol secretion over the rest 
of the day (Chida & Steptoe, 2009). As such, the correlation between CAR and other 
cortisol values is often low (Edwards, Clow, Evans, & Hucklebridge, 2001).  
Healthy cortisol functioning includes the rise and fall with normal daily stressors, 
as well as general diurnal rhythmicity. Short-term cortisol responses are typically due to 
acute stressors and are adaptive. Long-term alterations in cortisol responses (such as 
diurnal cortisol profiles) may be due to more chronic HPA activation.  Lower levels of 
overall cortisol are generally seen as favorable, as they indicate low levels of stress 
system activation. In diurnal patterns, steeper slopes are generally indicative of better 
health, while flattened slopes and other patterns of dysregulation usually signify less 
favorable health (Miller, Chen, & Zhou, 2007). Discerning “healthy” CAR is more 
complex, as greater morning increases may indicate a heightened HPA response, but 
findings have been inconsistent as to whether a diminished CAR is associated with better 
health outcomes (Chida & Steptoe, 2009).  
Recent research indicates that mean cortisol levels are more reliable than diurnal 
slopes in between-subjects analyses, with the minimal reliable measurement collected 
from at least three days of samples (Segerstrom, Boggero, Smith, & Sephton, 2014). Area 
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under the curve and diurnal slope require more days of collection to reach reliability 
(Segerstrom et al., 2014). Further, research suggests differences in overall cortisol levels 
may be due to genetic influences, sex (with women demonstrating lower levels than 
men), and nicotine use (Kirschbaum & Hellhammer, 1994). Thus, these factors should be 
taken into account when interpreting AUC and mean diurnal secretion as indicators of 
overall health.  
Cortisol and Cancer 
 Animal and human data support the link between cortisol rhythms, cancer 
incidence, tumor progression, and cancer prognosis (Eismann, Lush, & Sephton, 2010; 
Sephton & Spiegel, 2003). Disruptions in cortisol and circadian rhythms are linked to 
vulnerability to tumor incidence, faster tumor progression, and early mortality in cancer 
patients. Data supports that both biological (e.g., genetic) and behavioral (e.g., sleep 
disruption, stress) factors contribute to this link, including bidirectional relationships 
between circadian rhythms, endocrine activation, immune defenses, and psychosocial 
factors (Eismann et al., 2010). Research shows that 30-70% of cancer patients display 
disruptions in diurnal cortisol rhythms, including uncoordinated or erratic peaks and 
nadirs throughout the day, phase shifts, or generally flattened patterns at either 
abnormally high or low levels (Sephton & Spiegel, 2003). Aberrant patterns are most 
evident in patients with high tumor burden, poor performance status, and liver metastases 
(Sephton & Spiegel, 2003). As such, disrupted cortisol rhythms may be an indicator of 
progressing tumor status or the result of other biological effects of worsening 
psychosocial functioning (e.g., poor sleep due to pain or anxiety; Eismann et al., 2003; 
Sephton & Spiegel, 2003). However, the strongest evidence lies in the prognostic 
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significance of cortisol rhythms in cancer patients. Flattened diurnal rhythms have been 
shown to predict early mortality in a variety of cancers: breast (Sephton et al., 2000), 
renal (Cohen et al., 2012), lung (Sephton et al., 2013), and ovarian (Schrepf et al., 2015). 
 Flattening of the cortisol rhythm is also observed in response to stress.  In a study 
of breast cancer survivors’ affective and cortisol responses to daily stressors, survivors 
showed similar diurnal slopes and CAR as healthy controls, but less total cortisol on days 
of daily stress (Costanzo et al., 2012). The authors suggest that this may indicate a 
development of adaptive resilience or a blunted cortisol response to daily stress; 
although, the clinical significance of this hyporeactivity is unclear (Costanzo et al., 2012). 
Another study showed lower two-day average waking rise in cortisol in depressed breast 
cancer patients when compared to non-depressed (Giese-Davis, Wilhelm, et al., 2006). 
Similar results were observed with breast cancer survivors’ responses to upcoming 
mammograms: survivors had similar rhythms as healthy controls, but blunted overall 
cortisol on the day before and of their mammogram (Porter et al., 2003). On the other 
hand, several studies suggest breast cancer patients demonstrate higher cortisol levels 
than healthy controls (Abercrombie et al., 2004; McGregor & Antoni, 2009). 
Positive Affect and Cortisol 
 Theory. The literature on the relationship between PA and physiology among 
healthy populations has increased over the past decade. Several reviews have attempted 
to quantify the effects (Chida & Steptoe, 2008; Dockray & Steptoe, 2010; Howell et al., 
2007; Pressman & Cohen, 2005; Steptoe, Dockray, & Wardle, 2009; Vázquez, Hervás, 
Rahona, & Gómez, 2009). The overall findings indicate that PA and positive well-being 
are associated with better short-term and long-term objective health outcomes in healthy 
    
 14 
samples (Howell et al., 2007). As evidenced in both mood induction and longitudinal 
studies, for example, PA has related to longer survival and beneficial immune reponses 
(Chida & Steptoe, 2008; Dockray & Steptoe, 2010; Howell et al., 2007).  
PA may relate to positive health outcomes through what is known as the 
“Undoing Hypothesis” (Fredrickson & Levenson, 1998; Fredrickson, Mancuso, 
Branigan, & Tugade, 2000). The Undoing Hypothesis states that PA influences biology 
via encouraging a quick return to physiological baseline in the face of stress. Fredrickson 
et al. (2000) observed that after a stress-inducing task, participants who watched a film 
provoking contentment or amusement showed faster cardiovascular recovery (e.g., heart 
rate, finger pulse amplitude, blood pressure) than those who watched an a neutral or sad 
film. This data is in line with earlier work finding PA is associated with lower 
sympathetic activation, reflected in heart rate, skin conductance, body temperature, and 
muscle tension (Levenson, Ekman, & Friesen, 1990). However, experimental studies of 
the “undoing” effect of PA and on cortisol specifically are rare. The following sections 
summarize the state of the current literature on the associations between PA and cortisol, 
noting that nuances in state/trait PA as well as cortisol outcome measures interfere with 
the ability to draw firm conclusions on this complex relationship. 
 Evidence in healthy samples. Despite the growing literature on the role of PA in 
supporting overall health, the research on PA and cortisol is still evolving (Dockray & 
Steptoe, 2010; Pressman & Cohen, 2005). The topic has been only briefly reviewed in 
meta-analyses and reviews (e.g., Pressman & Cohen, 2005).  Several caveats exist when 
examining the current evidence. First, levels of cortisol differ in saliva, blood, and urine; 
caution must be taken in comparing studies that use different cortisol measurement 
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methods (Hellhammer, Wüst, & Kudielka, 2009). Second, the number of days of cortisol 
collection may greatly impact reliability of results. Diurnal slopes should be measured 
from at least 10 consecutive days if data are to be used for between-subjects analyses, and 
from at least 5-8 consecutive days if data are to be used for within-subjects analyses 
(Segerstrom et al., 2014).  Third, as diurnal rhythms and CAR are controlled by distinct 
biological processes, waking samples used for calculating diurnal slope must be anchored 
at the actual time of waking – e.g., not 30 minutes post-waking (Kraemer et al., 2006). 
Calculating slopes anchored beyond waking increases the risk of inflating or deflating the 
true diurnal slope value.  
To calculate diurnal cortisol slope, one should therefore first exclude the post-
waking cortisol sample from the analyses. Then, all remaining log-transformed cortisol 
points (waking, bedtime) should be regressed on collection time (numeric, hours).  The 
cortisol points should be from the entirety of the collection period; an average of daily 
slopes should not be used, as it contributes to data smoothing. The diurnal slope is 
represented by the unstandardized beta from the regression of all waking and bedtime 
points onto time (e.g., Turner-Cobb et al., 2000).  
State PA and overall cortisol levels. Initial evidence supports that increased state 
PA is associated with low cortisol secretion; however, reviews note that there are some 
inconsistencies. Pressman and Cohen (2005) found that when PA was induced in 
laboratory studies, acute cortisol typically decreased or showed no change; however, a 
few studies showed that cortisol levels increased. These inconsistencies may be the result 
of different methods of cortisol measurement, for example via plasma (e.g., Brown et al., 
1993; Codispoti et al. 2003) versus saliva (e.g., Hubert et al., 1993; Hubert & Jong-
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Meyer, 1991). Sampling times also ranged, such as from just pre-post (Hucklebridge et 
al., 2000) to every 15 minutes throughout induction (e.g., Hubert & Jong-Meyer, 1991). 
Sample sizes for theses studies have been typically small (N < 25), which may also 
contribute to inconsistencies.  
State PA and diurnal rhythms. The association between diurnal cortisol rhythms 
and state PA is noteworthy.  As previously reviewed, cortisol exhibits a predictable 
diurnal rhythm in healthy functioning: a peak about 30 minutes upon awakening, 
followed by a relatively steady decline throughout the day. Interestingly, PA follows a 
similar temporal pattern to that of the cortisol diurnal rhythm: positive emotions tend to 
peak early in the day and then substantially decline in the evening (Clark et al., 1989; 
Simpson et al., 2008; Thayer, 1987, 1989). NA, however, shows no such systematic 
diurnal rhythm (Simpson et al., 2008; Watson, Wiese, Vaidya, & Tellegen, 1999). This 
differentiation in diurnal affect patterns echoes the notion that NA and PA have distinct 
biological systems. Dockray and Steptoe (2010) note that studies do indeed find a 
coupling of diurnal cortisol patterns and PA.  Furthermore, PA shows a similar pattern to 
other endogenous processes, including body temperature and sleep-wake cycles (Watson 
et al., 1999).  
Trait PA and overall cortisol levels.  Among several large-scale studies, higher 
levels of trait PA tend to be associated with lower total cortisol secretion. One early study 
of 216 healthy adults showed that higher trait PA (as aggregated over several days) was 
associated with lower levels of overall cortisol secretion, even after controlling for age, 
gender, SES, BMI, smoking, and distress (Steptoe, Wardle, & Marmot, 2005). These 
findings were replicated in a later sample of 2,873 adults (Steptoe, O'Donnell, Badrick, 
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Kumari, & Marmot, 2008). Reviews mirror this notion, observing that PA is indeed 
typically linked to lower overall daily cortisol levels (Dockray & Steptoe, 2010; 
Pressman & Cohen, 2005; Steptoe, Dockray, & Wardle, 2009).  
Trait PA and diurnal rhythms. Studies on trait PA and diurnal rhythms show 
somewhat mixed findings, largely resulting from methodological issues. For example, 
one study found that trait PA and diurnal rhythms differed by gender: men with low trait 
PA showed flattened, but high, cortisol levels throughout the day, and women with high 
trait PA showed flattened patterns of low cortisol (Polk et al., 2005). However, salivary 
cortisol was sampled only over one 24-hour period, and diurnal slope calculations were 
anchored with a post-waking sample. Another study found that that eudaimonia, but not 
hedonia, was associated with the low, flattened patterns of cortisol (Ryff et al., 2004). 
However, the study again presented methodological issues with cortisol slope calculation 
by anchoring with a post-waking sample and averaging daily slopes together, thus 
contributing to data smoothing and minimizing the robustness of the data. Overall, 
caution is warranted in interpreting such results.   
Recent work attempts to elucidate the role of affect variability in the PA/cortisol 
relationship. Human et al. (2015) conducted two studies, which in aggregate suggested 
that less favorable cortisol profiles were associated with having either too much or too 
little PA variability.  Flattened slopes and high cortisol means were associated with high 
within-day PA variability among middle age adults, and with low across-week PA 
variability among older-adults.  The findings highlighted that variability in PA may relate 
to certain cortisol profiles. 
The evidence surrounding the role of arousal in the relationship between affect 
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and cortisol is another area of growing interest.  Item level analyses in the middle aged 
sample of Human et al. (2015) showed that alert was a stronger predictor of cortisol than 
the affects good and relaxed, highlighting the potentially important aspect of arousal in 
the PA/cortisol relationship. Another recent study highlighted a similar pattern of 
affective arousal on cortisol findings (Hoyt, Craske, Mineka, & Adam, 2015). A large 
sample of adolescents (N = 315) provided salivary cortisol samples and affective state 
ratings six times a day for three consecutive days. Principle component analysis 
identified four uncorrelated factors from mood ratings: positive/high-arousal (e.g., alert), 
positive/low-arousal (e.g., relaxed), negative/high-arousal (e.g.,  stress), and 
negative/low-arousal (e.g., sad). Analyses indicated that stronger positive/high-arousal 
was associated with steeper diurnal slope. Participants with positive/high-arousal had 
lower bedtime cortisol, but only at higher levels of PA intensity. Positive/low-arousal was 
not associated with cortisol. As such, a measure such as the Positive and Negative Affect 
Schedule (PANAS; Watson et al., 1988) may serve as a strong scale to capture such 
associations, given its inclusion of many high-arousal items (e.g., determined, 
enthusiastic, active).  
A recent large-sample study builds evidence that high trait PA is associated with 
stronger cortisol rhythmicity. Using a sample of 490 healthy adults, Miller et al. (2016) 
measured personality and trait PA through self and observer rating scales. Participants 
provided five salivary cortisol samples (waking, +30mins, +4hours, +9hours, bedtime) 
over four consecutive days. Cortisol values were log-transformed and regressed onto 
time. Slope calculations were anchored at waking but still included the 30-minute post-
waking sample, thus should be interpreted with some caution. Structural equation 
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modeling assessed the association of positive emotionality (extraversion/PA) with 
cortisol, and found a positive association with positive emotion with steeper slopes and 
smaller CAR, but no association with overall cortisol levels.  
Overall, the literature on PA and diurnal slopes should be considered cautiously, 
due to methodological concerns. Although evidence points to a general trend of steeper 
slopes associated with higher PA, aspects of affect variability and arousal may be 
confounding results. Methodological rigor is needed in calculating slopes in order to 
ensure true diurnal rhythms are represented, and not muddied by the anchoring by or 
inclusion of CAR samples.  
 Summary. The growing literature on PA and cortisol among healthy samples 
shows some promise of true association; however, all results must be considered 
critically in regard to methodology and the role of affect variability and arousal. First, 
state inductions of PA show evidence that increased PA is associated with lower cortisol 
levels. Second, diurnal state PA follows a similar temporal pattern as diurnal cortisol. 
Third, higher trait PA may be associated with lower total cortisol secretion. Fourth, 
higher trait PA may be associated with steeper cortisol slopes and smaller CAR. Greater 
methodological rigor is warranted including enduring a minimum of several collection 
days, anchoring slope at waking, and excluding post-wake samples in slope calculation 
(Kraemer et al., 2006; Segerstrom et al., 2014).  
PA and Cortisol in Cancer Samples 
The quality of the relationship between PA and cortisol may differ between 
cancer and healthy samples in clinically meaningful ways. Receiving a cancer diagnosis 
results in a range of emotional experiences, more intense and complex than one would 
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experience under normal, healthy conditions. Thus, the stress of having cancer may 
significantly alter the quality of emotional experiences. Indeed the majority of research 
on affect in cancer focuses on negative experiences such as distress and depression. The 
paucity of research on PA in cancer patients is remarkable, and highlights a gap in the 
field.  Given that relatively little is known about PA in cancer patients in general, the 
exploration of biological correlates makes for an even more elusive topic (Davis et al., 
2015). Another critical point is that neuroendocrine function is altered when the body is 
fighting tumors (Sephton & Spiegel, 2003). Thus, findings from research of cortisol 
function in healthy populations may not be fully valid among cancer samples, but may 
nonetheless be informative. 
To my knowledge, only four studies have investigated the association of PA and 
cortisol in cancer patients (Table 1). The first study compared a sample of breast cancer 
survivors to healthy controls (Porter et al., 2003). Longitudinal data assessed whether 
predicted changes in cortisol slope, overall mean levels, and reactivity to a cancer-
specific stressor (mammogram). Cortisol and psychosocial data were collected for three 
days at baseline (one month before mammogram), and for three days at the time of the 
mammogram (day before, of, after). Baseline slope was calculated via a nested, mixed-
linear model. Slopes were not calculated for the one-day stress samples; instead, cortisol 
reactivity was calculated as the slope from regressing average cortisol level during the 
stress days onto baseline. The authors found that higher baseline PA was associated with 
lower cortisol reactivity to mammogram when compared to healthy controls. 
The second study was a cross-sectional investigation on whether emotional 
expression was related to healthier cortisol rhythms among metastatic breast cancer 
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patients (Giese-Davis, DiMiceli, Sephton, & Spiegel, 2006). Metastatic breast cancer 
patients were videotaped during the first session of expressive-supportive group therapy 
and provided salivary cortisol samples (three days, four samples per day). Hierarchical 
linear regressions assessed the relationship between PA expression and diurnal cortisol 
slope and average cortisol. Similar to the findings from Porter et al. (2003), the authors 
found that increased positive emotional expression (affection, humor, joy, etc.) was 
related to lower mean cortisol levels, even after controlling for negative emotional 
expression. NA expression, but not PA, was associated with steeper diurnal slope.  
The third study was conducted by the same group and explored depression and 
stress in metastatic breast cancer patients (Giese-Davis, Wilhelm, et al., 2006). The 
overall findings of that study indicated that depressed cancer patients had less PA and 
lower waking cortisol levels. However, no direct analyses were conducted between PA 
and cortisol, thus no conclusions can be drawn about their relationship from that study.  
The fourth study was on a sample of breast cancer survivors (Costanzo et al., 
2012). Drawing from a large national survey, survivors were age, sex, and education 
matched to healthy controls. Cortisol was measured via four samples per day, over four 
days; slopes were anchored at waking. Findings showed that longer time since diagnosis 
was associated with higher levels of PA and lower levels of total cortisol. However, the 
relationship between PA and cortisol was not directly measured, thus conclusive 
associations may not be drawn. Nevertheless, it may be that longer time since diagnosis 
allows for more space for successful coping, reduced immediate distress about treatments 
or even reoccurrence, thus improving PA and reducing overall physiological stress. 
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Indeed some studies have shown that meaning of life scores may increase over time in 
cancer patients (Hsiao et al., 2013).  
Costanzo et al. (2012) also found that on days where daily stressors occurred, 
cancer survivors showed less pronounced decline in PA and lower overall cortisol levels, 
but similar patterns of diurnal cortisol slope and CAR in comparison with healthy 
controls. Again, the direct relationship between PA and cortisol was not specifically 
assessed. Nevertheless, the results demonstrate an element of emotional resiliency among 
cancer survivors in that they maintained some PA and low HPA reactivity in the face of 
stress. The analyses suggest some degree of relationship between experiencing stress, 
maintaining PA, and minimal disruption of cortisol patterns.  
Summary. In light of the minimal amount of published research on PA and 
cortisol in cancer patients, firm conclusions may not be made. Nevertheless, initial 
patterns do appear in the work presented and may inform future hypotheses. Specifically, 
state and trait PA seemed to relate to overall cortisol levels in these samples of cancer 
patients. In particular, cancer patients who had high PA showed lower overall cortisol 
levels, even in times of cancer-specific stress. Unlike the findings among the healthy 
literature, PA did not seem to show a firm relationship with diurnal cortisol rhythms in 
these samples of cancer patients. As with healthy samples, conclusions on CAR cannot 
be drawn.  
Limitations of Current Literature 
A review of the current literature on PA and cortisol sheds light on several 
limitations in these cancer studies. Several of the limitations are common to those 
observed in research among healthy samples as well.  
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 Measuring PA. Lack of standard measures and interchangeable terms referring to 
PA and well-being leads to concerns of reliability and validity. Without consistent 
application of the term “PA”, especially as it relates to broader concepts of subjective 
well-being and eudaimonia, the nuanced associations of PA with biology will be lost. 
However, one of the most common measures of PA is the Positive and Negative Affect 
Schedule (PANAS; Watson et al., 1988), which is used throughout the healthy and cancer 
literature.  
 Furthermore, the lack of differentiation between state and trait PA invokes 
confusion in understanding underlying physiological mechanisms (Pressman & Cohen, 
2005). Affective states are closely associated with central nervous system activation, 
relating directly to both neuroendocrine and cardiovascular functioning (Critchley, 2005), 
while positive traits such as optimism may affect physiological processes by inducing 
successful coping strategies (Scheier, Carver, & Bridges, 2001). Measuring self-reported 
average affect over a brief, set amount of time (e.g., using the PANAS anchored to the 
past week) may be one method to overcome this issue. Such an approach may be a more 
valid way of capturing affective experiences by honoring the emotional fluctuations that 
may occur (for example, week by week with treatment schedules) throughout the cancer 
journey.  
 Measuring cortisol.  Reliable collection and calculation of cortisol remains an 
issue across research among both healthy subjects and cancer patients. For example, 
many studies include post-wake samples in their calculation of cortisol slope or use too 
few of days to reliably calculate the cortisol variables. Reporting of multiple cortisol 
metrics is also imperative, given that overall secretion levels, CAR, and diurnal slope 
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capture different, and somewhat independent, processes (Chida & Steptoe, 2009; Wüst, 
Federenko, Hellhammer, & Kirschbaum, 2000). For example, mean cortisol levels 
provide no information as to how steep or flat as slope is.  
Sample and design issues. All four of the studies on PA and cortisol in cancer 
were on breast cancer patients, limiting generalizability to other cancer samples, and in 
extension, to samples that include males. Gender associations with cortisol may have 
influenced the findings of the studies, as gender effects are seen in overall cortisol levels 
(Kirschbaum & Hellhammer, 1994), CAR (Clow, Thorn, Evans, & Hucklebridge, 2004), 
and slope (Human et al., 2015). Lack of generalizability extends to several of the healthy 
sample studies as well, with some having strikingly small samples sizes (e.g., 5 
experimental participants and 5 controls, all men; Berk et al., 1989), all one gender, or of 
a certain age range (e.g., Ryff et al., 2004; Steptoe, Gibson, Hamer, & Wardle, 2007).  
More research is needed with other cancer samples, such as lung cancer, that are 
inclusive of both genders, wide age range, and have larger sample sizes. 
 A final and related critique of the current literature is that studies differ on the 
control variables used in analyses. Costanzo et al. (2012) could not control for certain 
cancer-specific variables since the data came from a large-scale aging study where these 
variables were not assessed. The other cancer studies did not use control variables in 
primary analyses or used analyses that did not allow for them. Most importantly, NA is 
not consistently controlled for in both healthy and caner studies (Steptoe et al., 2009). 
Accounting for the effects of NA is essential to understanding the unique contributions of 
PA in salutary biological effects. Other potential confounding variables that associate 
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with PA include gender (as previously discussed), age (Mroczek & Kolarz, 1998), socio-
economic status (Diener & Biswas-Diener, 2002), and education (Keyes et al., 2002). 	  
A Cancer-Specific Integrated Model 
	   While the literature on physiological processes associated with PA in healthy 
samples is in its infancy, research among cancer patients can highlight important 
processes and outcomes. In this light, I present an original integrated model driven by 
theory and based on the previously reviewed literature (Figure 1). I propose that, in 
cancer patients, PA and eudaimonia differentially interact with distress effects on the 
brain and HPA system, and that these effects are different from those seen in healthy 
samples. Neurobiological mediators are presented, yet an in-depth review of them is 
beyond the scope of this paper. The model is presented to create a context for more 
specific future research and to spark foundational research upon which to build. 
 Pressman and Cohen (2005) suggest that PA may have a direct effect on HPA 
functioning in healthy samples. However, in cancer patients, PA alone may not be strong 
enough to have a main effect on biology. The direct effects of PA on the HPA may be 
masked in cancer due to increased psychological stress, as well as tumor and treatment 
effects on physiology. Pressman and Cohen (2005) put forth a second model that suggests 
PA works indirectly on biology through buffering stress and immune responses.  
However, the model lacked specific theories of mechanisms, did not include the role of 
neurobiological components, and was not cancer specific. Thus, my proposed model 
captures these elements to present how PA may relate to cortisol in cancer patients.  
Cancer patients experience distress (Zabora et al., 2001; Figure 1, arrow A).  
Perceived stress affects the HPA system (Chrousos, 1998; arrow B) and other emotion-
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related brain structures including the prefrontal cortex (PFC), ventral striatum, amygdala, 
and hippocampus (Arnsten, 2009; arrow C).  These areas of the brain may also interact 
with HPA function (Chrousos & Gold, 1992; Dedovic et al., 2009; Kern et al., 2008; 
arrow D). Evidence is building that positive psychological processes may have main 
effects with these same brain regions (arrows E and F). Positive affect may stem from the 
activation of “hedonic hotspots” in the limbic system and cortex, thus producing the 
experience and awareness of state positive emotions (Kringelbach & Berridge, 2009).  
The chronic experience of state PA (i.e., trait PA) then in turn strengthens these systems 
(Kringelbach & Berridge, 2009). Increased PA is associated with increased left 
frontocentral activation (Urry et al., 2004), while eudaimonic processes are associated 
with the frontal cortex, amygdala, insula, and cingulate cortex (Heller et al., 2013; Lewis 
et al., 2014; Urry et al., 2004).  In relation to the HPA, people with greater ability to 
maintain activation in brain reward systems (i.e., PFC and striatum) demonstrate higher 
PA, greater eudaimonic well-being, and lower overall cortisol levels (Heller et al., 2013).  
The experience of PA broadens one’s cognitive and behavioral repertoire, leading 
to a building of physical, social, intellectual, and emotional resources (“Broaden and 
Build”; Fredrickson, 2001). This creation of wide spreading psychological resources 
mirrors the concept of building eudaimonic well-being (Ryff, 1989). Engaging in these 
resources then feeds back to creating more positive emotions. This “Broaden and Build” 
process is evident in cancer patients (arrow G). Feelings of joy, inner peace, and 
happiness are associated with increased quality of life in patients, with joy specifically 
being associated with having a more meaningful life and a good death (Lin & Bauer-Wu, 
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2003). Other studies suggest that patients with higher PA also experience more feelings 
of meaning and peace (Voogt et al., 2005).  
If PA and eudaimonia indeed interact to build each other, their unique effects on 
cortisol in cancer may be difficult to parse out. Nevertheless, I propose that PA and 
eudaimonia, although interrelated, produce different cortisol outcomes based on two 
different, theoretically-driven mechanisms. First, the research suggests that state and trait 
PA relate to cortisol reactivity (i.e., total cortisol secretion), but perhaps not as strongly to 
cortisol slopes, in cancer patients. I propose this may be due to Fredrickson’s “Undoing 
Hypothesis” (Fredrickson & Levenson, 1998; Fredrickson et al., 2000; arrow H1).  The 
Undoing Hypothesis suggests that the experience of PA in the face of stress helps the 
body return to a physiological baseline faster than neutral or negative emotions do. In this 
way, state PA (and by extension trait PA) may work to “undo” similar HPA stress 
responses, by activating parts of the brain such as the PFC and hippocampus that help 
initiate the stop of cortisol production (Chrousos & Gold, 1992). In other words, once a 
stressor is faced, patients who also experience PA are better able to discontinue the stress 
response, thus allowing for a lower accumulation of total cortisol (arrow H2).  
PA in this sense may be conceptualized as a “short term” process, by preventing 
accumulation of cortisol through “undoing” the negative physiological effects of acute, 
rather than chronic, stress. Indeed stressors in the cancer studies may be described as 
short term: daily stressors (Costanzo et al., 2012), current discussion of cancer-related 
topics (Giese-Davis, DiMiceli, et al., 2006), or a cancer-related stressor happening the 
next day (Porter et al., 2003). Of note, the women in Costanzo et al. (2012) endorsed 
experiencing stress, but still maintained high PA, and showed lower overall cortisol 
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output. Although stress perceptions were not directly measured in the other studies, 
similar processes may have been at play, as they too observed that patients with high PA 
showed lower total cortisol levels (Giese-Davis, DiMiceli, et al., 2006) and lower cortisol 
reactivity (Porter et al., 2003) to their cancer-related stressors. Given that trait PA may be 
conceptualized as the frequent and consistent experience of state PA, one might consider 
too that trait PA would also be associated with lower levels of overall cortisol because of 
this undoing process.  
Despite evidence among healthy samples, there is a lack of firm support that PA 
may relate to longer-term cortisol outcomes such as diurnal rhythms. Since this point is 
drawn from only four studies of breast cancer patients, more research is certainly needed 
in this area. However, it may be that eudaimonia, a more enduring process that involves 
building coping skills and psychological resilience, is a more potent positive 
psychological process than PA alone in cancer patients. Eudaimonia is therefore more 
likely buffer the effects of stress, through using broad psychosocial resources to 
adaptively adjust appraisals, coping, and emotional outcomes (arrow I1; Fredrickson, 
2001). This buffering effect is likely to influence biological indicators of chronic (rather 
than acute) distress, such as disrupted diurnal rhythms (Figure 1, arrow I2). Although a 
thorough review of studies was outside the scope of this paper, initial evidence exists that 
improving experiences of eudaimonia, such as meaning making through psychotherapy, 
results in steeper cortisol slopes in cancer patients (Hsiao et al., 2012).  Extending from 
this, a recent study on hedonia and eudaimonia in ovarian cancer patients utilized 
structural equation modeling and found that eudaimonia was associated with lower tumor 
norepinephrine; however, PA was not (Davis et al., 2015).  It may be that although PA 
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and eudaimonia are related, the more enduring processes involved with building 
eudaimonia may be more strongly associated with robust biology (e.g., diurnal rhythms) 
than PA alone.  
It also remains unknown if total cortisol output relates to diurnal slopes in a 
similar way that PA relates to eudaimonia – that they are proxies of each other and work 
in a feedback process (Fredrickson, 2001). Indeed, the relationships between cortisol 
output and diurnal slope are yet to be fully understood in cancer patients (Giese-Davis, 
DiMiceli, et al., 2006).  As PA works to produce eudaimonia through Fredrickson’s 
Broaden and Build theory, it may be that the respective effects on cortisol work in a 
similar way. If a patient is better able to maintain low cortisol reactivity (i.e., low means 
and quick return to baseline HPA function), the patient may in turn see an overall 
maintenance of cortisol rhythms and a preservation of steeper slopes. The PA and 
eudaimonia relationship may work in parallel to the cortisol output and cortisol 
rhythmicity relationship.  
The final stage of the model relates to long-term outcomes. Psychological 
resilience in the short-term (PA and overall cortisol) coupled with resilience in the long-
term (eudaimonia and diurnal rhythms) work jointly to influence other downstream 
processes, such as inflammation. These psychoneuroimmune and endocrine processes 
then relate to health outcomes such as disease progression, survival, and quality of life 
(Lutgendorf & Costanzo, 2003). 





THE PROPOSED STUDY 
Given the state of the current research, PA seems to relate to biology in 
meaningful ways. However, the relationship to cortisol may differ between cancer 
patients and the healthy population.  Due to cortisol’s particular importance in cancer 
outcomes, this topic deserves greater attention.  While PA seems to be associated with a 
broad range of cortisol outcomes in healthy samples, data from cancer patients 
demonstrate more limited associations, implying that certain positive experiences may be 
related to specific cortisol responses or that mind-body relationship may be masked by 
disease-related variables.  The integrated model highlights recent research on 
neurobiological pathways as well as theoretically-driven mechanisms.  Future research 
will clarify these processes, leading to improvements in clinical applications and policy.  
To help begin filling in the scientific gap concerning the PA/ cortisol relationship 
in cancer patients, the current study will focus on the proposed direct pathway between 
PA and cortisol (Figure 1, arrow H2; Figure 2). The study will use a sample of lung 
cancer patients, given the relative paucity of literature on psychobiological processes in 
this vulnerable population. The study will test the association between PA experienced 
over the past week and subsequent cortisol outcomes over the following ten days.  
Research Question and Hypotheses 
Aim 1. Understand the frequency and quality of PA among lung cancer patients. 
Explore what elements of the person (e.g., demographic variables) and his or her cancer 
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journey (e.g., medical variables) may be associated with experiencing more positive 
affect.  The primary research question is: What positive emotions, and to what degree, do 
lung cancer patients experience in a given week? What are the demographic and medical 
variables that may relate to experiencing more positive affect among these patients?  
Hypothesis 1.1. Positive affect in this sample will be described at an item, 
subscale, and construct level. Patients will experience moderate PA, and patients will 
report more PA than NA, as tested by the PANAS.  
Hypothesis 1.2.  In exploratory analysis, positive and negative affect items will 
emerge as separate factors.  
Hypothesis 1.3. Variables that reflect lower disease burden (e.g., lower stage, no 
current treatment, longer time since diagnosis) will be associated with higher PA.  
Aim 2. Test the relationship between positive affect and cortisol outcomes. The 
primary research question is: Does positive affect relate to diurnal cortisol measures in 
lung cancer patients?  
Hypothesis 2.1. Higher PA will be related to lower mean cortisol levels. 
Hypothesis 2.2.  Higher PA will be related to steeper diurnal cortisol slope.  
Hypothesis 2.3 PA will more strongly relate to mean cortisol than to diurnal 
slope.  





Data were collected as part of a larger study investigating the prognostic 
significance of circadian disruption in lung cancer patients and the utility of a 
mindfulness-based coping skills intervention (University of Louisville IRB 13.0508). 
Recruitment 
 Study personnel were trained by the University of Louisville to ethically conduct 
human subjects research. The University of Louisville and the James Graham Brown 
Cancer Center provided hospital accreditation to recruitment personnel in order for them 
to have patient contact in the clinic. Lung cancer patients were recruited for the study 
from thoracic oncology clinic at the James Graham Brown Cancer Center in Louisville, 
KY. Recruitment personnel reviewed all patients listed on the clinic’s outpatient schedule 
and assessed each patient’s eligibility through the use of a standardized screening chart 
review. The chart review included a summary of inclusion/exclusion criteria as well as 
other relevant medical and demographic factors. Attending physicians were made aware 
of which patients met study criteria. Physicians then briefly introduced the study to 
potential participants after their appointment, at which time the recruitment personnel met 
with the patient. Patients were given information regarding the purpose and requirements 
of the study, presented with opportunities to ask questions, and invited to provide consent 
for participation. If the patient enrolled, the recruitment personnel worked closely with 
the patient to explain the instructions for data collection and the process of the study in 
detail.   
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Participants 
Patients were recruited between February 2014 and October 2016. To have met 
study eligibility criteria, patients must have been between the ages of 18 to 85, have 
received a diagnosis of non-small cell lung cancer with the previous five years, have no 
concurrent medical diagnosis likely to influence short-term (i.e., six-month) survival, live 
within a 120-mile radius of Louisville, KY, have no history of psychiatric hospitalization, 
no history of drug or alcohol abuse within the previous two months, and no known 
immune compromising conditions such as hepatitis or HIV/AIDS.  Sociodemographic 
and cancer related history and treatment variables were derived from chart review at the 
time of eligibility assessment.   
 Ninety-three patients were invited to participate in the study during the 
recruitment period. Of those invited, 67 chose to enroll at baseline. Six of these patients 
withdrew during baseline collection for reasons such as current health issues or current 
social stressors. The final sample of patients for the current study was therefore 61 
patients. Full cortisol data was completed for 57 of these patients.  
Data Collection Procedure 
Informed consent. All study procedures were conducted in accordance with 
guidelines set forth by the University of Louisville Human Subjects Protection Program. 
All study participants provided informed consent and Health Information and Privacy 
Protection Act (HIPPA) documents prior to enrollment.  
All participants were enrolled in a larger study examining the prognostic 
significance of circadian disruption in lung cancer and the utility of a piloted 
mindfulness-based coping skills intervention. Data for the current study consisted only of 
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baseline data collection. After informed consent, participants were provided with a 
baseline questionnaire packet, a ten-day daily brief questionnaire packet, a salivary 
cortisol collection kit containing 20 salivary collection tubes (“salivettes”; Walter 
Sarstedt Inc., Newton, North Carolina), and a wrist-worn actigraphy watch. A trained 
phlebotomist drew three vials of blood for assessment of immune and metabolic 
functioning. Participants were compensated with a $100 pre-paid gift card for completing 
baseline data collection in full. Participants were invited to participate in a mindfulness-
based coping skills intervention over the following three months, and a follow-up 
assessment similar to baseline after completing the intervention.   
Demographic and medical variables. Demographic and medical history 
variables were derived from the medical chart at the time of recruitment.  Participants 
were also instructed to complete a set of demographic items in the beginning of the 
baseline questionnaire packet.  
 Psychosocial questionnaires. Participants were asked to complete a set of 
psychological measures consisting of both risk and resilience factors, which took about 
an hour and a half to complete. As part of this questionnaire packet, participants 
completed the Positive and Negative Affect Schedule (Watson et al., 1988) coded to 
assess affect over the past week.  Participants also were given a ten-day daily 
questionnaire packet, consisting of brief questionnaires on variables that may affect 
cortisol (e.g., sleep, medications); these questionnaires took about 10 minutes to complete 
each day.  
Salivary cortisol. The daily questionnaire packet provided detailed instructions 
on salivary cortisol collection, as well as a supplemental document for the participant to 
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note any deviations from the data collection protocol. Participants were provided with a 
salivary cortisol collection kit. The kit includes 20 pre-labeled salivettes, each labeled 
with a sticker for recording the participant’s identification code, exact time of saliva 
sample, and the date. Salivettes were organized by sample time and day of collection in 
the kit. The kit was provided in a large zip-lock bag and included a sharpie marker to 
maximize participants’ ability to accurately record data on the salivette. Participants were 
instructed to provide two salivary samples each day for ten consecutive days: one sample 
immediately upon awakening and one sample at bedtime. To provide a saliva sample, 
participants removed the cap from the salivette and placed the entire cotton swab in their 
mouth, keeping the swab there until it was fully saturated (about two minutes). While the 
swab was in their mouth, participants noted their identifier code, and the exact time and 
date on the salivette, using their actigraphy watch as a reference point. Participants then 
spit the saturated swab back in the salivette tube and closed the cap tightly. Participants 
then placed the fully labeled sample in the zip lock bag and kept all collected samples in 
the refrigerator.  All saliva samples are kept refrigerated until they are returned to the lab 
for processing. 
Recruitment personnel suggested that the cortisol collection kit be kept at the 
participant’s bedside in order to maximize the ease and reliability of collecting the 
morning sample immediately upon awakening. To ensure accuracy of data collection, 
study personnel emphasized to the participants that the morning saliva samples must be 
taken at the moment of awakening. Any delay in this sample will result in an inaccurate 
waking cortisol value and may instead capture CAR. Participants were reminded of the 
importance of recording the exact time of all saliva samples on the specified label on the 
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salivette. They were instructed not to eat, drink, smoke, chew gum, or brush teeth 30 
minutes prior to any saliva sample, which minimizes any risk of contaminating the 
cortisol data. They were advised to note any late sample takings, difficulties they had, or 
accidental contaminations of any saliva sample on a supplemental document provided 
with the daily questionnaire. Study personnel called the participant around the third day 
of the 10-day collection to check in on the status of data collection and clarify any 
questions or concerns the participant may have had.  
Data retrieval. During the data collection, study personnel contacted the 
participant to schedule a time to meet and collect the baseline data and provide the $100 
prepaid gift card. At the scheduled meeting, all study materials were returned. The 
participant was compensated and was instructed on further study protocol (i.e., 
intervention and three month follow-up). The study personnel returned to the lab on the 
University of Louisville Belknap campus to file the questionnaire data and begin 
processing the biological data.  
Cortisol assay. Once salivary cortisol samples were returned to the lab, they 
remained refrigerated until prepared for assay. All saliva samples were processed within 
one month of the first sample, but typically within a few days of the last sample. 
Salivettes were centrifuged for 15 min at 453 g at 25 °C. Any abnormal appearance in the 
cotton or saliva was recorded. Samples were pipetted into microcentrifuge tubes, placed 
in freezer boxes, and frozen in a -80 °C freezer until assayed. The cortisol levels were 
assayed using an enzyme-linked immunoabsorbent assay (ELISA) developed for use in 
saliva (Salimetrics, Inc., State College, PA). Along with participant assay results, samples 
of known high and low concentration cortisol were evaluated to obtain reliability 
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estimates for the assay. Assay sensitivity was 0.007 µg/dL. The average inter-assay and 
intra-assay coefficients of variation (CV) were under 10% for both the low and high 
controls.  
Measures 
Demographic and medical data. In order to explore demographic and cancer-
related individual difference factors associated with PA, an array of variables were 
collected during medical chart review and in the baseline questionnaire packet. 
Demographic variables included age, gender, race/ethnicity, household income, and years 
of education. Medical variables of interest included age at diagnosis, cancer stage, 
smoking history, current or past treatment (radiation, chemotherapy), and current 
medications. Cancer stage and date of diagnosis were confirmed through chart review. 
There were no missing data for medical and demographic variables, except smoking. One 
individual opted not to answer current smoking status. Of patients with a smoking history 
(n=59, including current smokers), four did not answer how many years they smoked (the 
distribution remained normal). Smoking history was quantified as pack-years, which is 
the number of packs of cigarettes per day multiplied by years smoking. Four current 
smokers indicated a difference between current pack years and historical pack years, all 
showing a decrease in current smoking; in these cases, historical pack years was used as 
their total pack years number to account for smoking over the lifetime. Control variables 
used in Aim 2 analyses were derived through theoretically-based and data-driven 
verification. 
Positive affect. The Positive And Negative Affect Schedule (PANAS) was the 
primary measure used to assess affect (Watson, et al., 1988). The PANAS is a 20-item 
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self-report measure, which assesses positive and negative affect scores on a five-point 
scale ranging from very slightly or not at all to extremely. The total score from the ten 
positively valenced items and the ten negatively valenced items comprise the PA and NA 
subscales, respectively. The PA subscale reflects the extent to which the participant feels 
positive mood states such as, “inspired”, “interested”, and “excited”. The NA subscale 
captures aversive mood states such as “irritable”, “guilty”, and “scared”. The PANAS 
may be coded to either momentary affect, general affect experienced over the past week, 
or other set timeframes; the PANAS was coded to the past week in this current study. The 
measure was originally validated and developed in an undergraduate sample. The internal 
consistency of the measure is excellent, with alpha coefficients for the PA scale ranging 
from .86 - .90, and for the NA scale ranging from .84 - .87 (Watson et al., 1988). The 
PANAS has been used in cancer populations, with alpha coefficient of the PA scale at .88 
and of the NA scale at .91 (Manne & Schnoll, 2001). The PA-NA inter-correlation ranges 
from -.12 to -.23, indicating quasi-independence between the subscales (Watson et al., 
1988). The test-retest reliability for the PANAS coded to the past week is .47 for both PA 
and NA (Watson et al., 1988).  
The positive affect items of the Center for Epidemiologic Studies Depression 
scale (CES-D) were used as a secondary measure of PA. The CES-D is a popular, 
standardized measure used to assess depressive symptoms (Radloff, 1977). It is 
comprised of a total of 20 items: 16 items measuring depressive symptoms and behaviors, 
and four items assessing positive affect. Participants are asked to rate the frequency of the 
feelings or behaviors over the past week. Items are scored on a four-point Likert scale, 
ranging from Rarely or None of the Time to Most or All of the Time.  Total score is 
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comprised of the sum of the depressive symptoms items and the reverse score of the 
positive affect items. The measure has high internal consistency (alpha coefficients 
ranging from .85 - .90).  
The positive affect items of the CES-D include: I felt that I was just as good as 
other people, I felt hopeful, I was happy, I enjoyed life. These items were originally 
added to the CES-D in order to break tendencies towards response set and to assess the 
absence of PA in depressed people (Radloff, 1977). However, in a large sample of both 
cancer (n = 434) and healthy controls (n = 236), factor analysis found that these PA 
items consistently loaded onto a separate factor that had relatively low correlation with 
the depressed affect scale (r = .14), which is consistent with other factor analysis studies 
(Schroevers et al., 2000). These findings suggest that the PA items of this measure likely 
represent a construct independent of depression (i.e., positive affect, rather than the 
absence of depressive symptoms). Cronbach’s alpha for PA in that study was 0.75 for the 
cancer sample and 0.76 for healthy controls (Schroevers et al., 2000).  Therefore, in the 
current study, the total score of PA items (not reverse scored) on the CES-D was used as 
a secondary measure of PA (CES-D PA). This secondary measure of PA served as both 
construct validity for PANAS-PA as well as a method to expand the span of arousal that 
could be captured between the PANAS and CES-D PA items.  
In both psychosocial measures (PANAS, CES-D PA), data were reviewed for 
outliers. Missing data was addressed through imputation. Consistent with the laboratory 
protocol for missing data, no data were imputed if over half of the data were missing for a 
subscale. If less than or equal to half of the data were missing, items were replaced with 
the subscale mean for that individual. Following this criterion, item-level data were 
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replaced for six individuals for the PANAS.  Four patients had missing one or two items 
replaced. One patient had four missing data points replaced. One patient missed exactly 
half of the PANAS items (equally split between PA and NA), thus the subscale means 
were replaced for those ten missing items, and the patient was kept in the dataset. Four 
individuals had item-level data missing for the CES-D; three patients had one missing 
item, and one patient had two missing items.  Two people did not complete the CES-D, 
but these individuals were retained in the overall dataset (with no CES-D score) due to 
small sample size; these individuals did not significantly differ from the overall dataset 
on demographic or medical features. Missing data were imputed before total or sum 
scores were calculated.  
Cortisol. Salivary cortisol data was collected over ten days to maximize the 
reliability of intended cortisol outcome variables (Segerstrom et al., 2014). The sampling 
times of waking and bedtime were selected because they will allow calculation of the 
diurnal cortisol slope (Sephton et al., 2000). Raw cortisol values were log-transformed 
prior to analysis to account for known skew, and diurnal mean cortisol was calculated 
using the log-transformed daytime values. Cortisol values were regressed on collection 
time to yield a diurnal cortisol slope for each individual (Sephton et al., 2000; Sephton et 
al., 2013). Final cortisol outcome variables consisted of mean log waking value, mean log 
bedtime value, overall diurnal log mean, and diurnal slope calculations over the ten-day 
collection period. 
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Statistical Analyses  
 Data reduction and scoring.  Questionnaire data.  Two research assistants 
entered questionnaire data into independent databases. The databases were compared to 
ensure correct entry. Questionnaires were scored after missing data were replaced. 
 Cortisol. Raw cortisol data consisted of an exact collection time recorded by 
research subjects on saliva collection tubes and a laboratory-generated cortisol value 
(µg/dl) from the assay. Collection times were recoded first to military time (i.e., 8:30 PM 
becomes 20:30) and then transformed to numeric time (i.e., 20:30 becomes 20.5 hr). 
Bedtime samples collected after midnight (e.g., bedtime sample collected at 12:30 AM) 
were recoded as occurring beyond 24:00 hours (e.g., 12:30 AM coded as 24.5 hr, 1:15 
AM coded as 25.25 hr, etc.). Assay results that were too high to be read by the standard 
curve were diluted and re-assayed with subsequent results adjusted accordingly. Sample 
collection times reported by subjects were checked and corrected using wrist-worn 
actigraphy data, collected for aims of the parent study. Several baseline cortisol samples 
(7.5%) had collection times that were modified based on one of the following reasons: 1) 
to ensure records were cohesive in using the military time format, 2) to exclude samples 
collected more than 15 minutes after actigraphy-based waking as the salivary waking 
samples, as they instead reflect cortisol awakening response, 3) to correct collection time 
of bedtime samples such that they were not listed as having been collected after 
participants were asleep. Prior to calculating cortisol variables of interest, raw cortisol 
values were transformed using the natural log to account for known positive skew. 
Diurnal slope was calculated by regressing the log-transformed cortisol values 
(waking, bedtime) on time (numeric, hours). A maximum of twenty total cortisol samples 
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per participant were therefore be entered into the regression. The diurnal slope is 
represented by the unstandardized beta from the regression. Values for the diurnal 
cortisol slope are generally negative between 0.9 and -0.9 with higher numbers indicating 
flattened or aberrant slopes.  Mean raw and log-transformed cortisol values were 
calculated by averaging all cortisol data points collected at waking and bedtime, both 
together and separately.  
Sample characteristics. Characteristics of the sample were determined by 
calculating frequency, percentage, and mean data on demographic variables.  
Descriptive statistics. Descriptive data in the form of means, standard deviations, 
and percentages were calculated for independent and dependent variables.  
Tests of hypotheses.  Descriptive analyses were used to determine the fit of the 
data with regard to all assumptions of analyses. All assumptions were met prior to 
analysis, and significant outliers were removed if present. Statistical analyses for each 
Aim are described below.  
 Aim 1.  Hypothesis 1.1 was approached in an exploratory manner. Descriptive 
statistics (mean, standard deviation, range, frequencies) were used to understand the 
overall distribution of positive affect (PANAS items, CES-D positive items). A within-
subjects two-tailed t-test tested the hypothesis that patients would report more PA than 
NA (PANAS subscales). To explore PA on the construct level, bivariate correlations 
between the PA subscale of the PANAS and the PA items of the CES-D and between the 
PA and NA subscales of the PANAS were conducted.  
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Hypothesis 1.2 was examined through an exploratory factor analysis, in which it 
was hypothesized that PA and NA items from the PANAS would fall into two distinct 
factors in this lung cancer sample. 
Hypothesis 1.3 assessed the relationship between PA and demographic/medical 
features, hypothesizing that variables reflecting lower disease burden (e.g., lower stage, 
no current treatment, longer time since diagnosis) would be associated with higher PA. 
Bivariate correlations assessed the strength of the relationship between PANAS scores 
(subscales, items) and CES-D scores (subscale, items) and demographic/medical factors. 
Pearson r correlations were used for continuous, linear variables (e.g., age, time since 
diagnosis); point-biserial procedure of Pearson r correlations was used for dichotomous 
variables (e.g., gender). Data used in Pearson r correlations met assumptions of linearity 
and normality prior to analyses. If assumptions were violated, Spearman rank correlations 
were used. Spearman rank correlations were used for ordinal data (e.g., cancer stage). 
Data used in Spearman correlations met the assumption of monotonicity. All correlations 
used two two-tailed tests of significance. 
Aim 2.  For regression analyses of Aim 2 (Hypotheses 2.1 and 2.2), four 
regressions were conducted for each of the four cortisol dependent variables. Primary 
analyses utilized data-driven covariates; ad-hoc analyses utilized both data-driven and 
theoretically-derived covariates. Across Hypotheses 2.1 and 2.2, the first regression 
tested PANAS PA and data-driven covariates (Kraemer et al., 2001). The second 
regression tested PANAS PA included both data-driven and theoretically-driven 
covariates; theoretical covariates were decided based on previous literature (i.e., NA) and 
lab conventions (i.e., corticosteroid use), but were limited in number due to small sample 
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size. The third regression tested PANAS PA and CES-D with data-driven covariates 
(Kraemer et al., 2001), and the fourth regression tested PANAS PA and CES-D with both 
data-driven and theoretically-driven covariates.  
 Hypotheses 2.1 and 2.2 were analyzed using hierarchical linear regressions. 
Regressions met assumptions of linearity, normality of residuals, and homoscedasticity 
prior to analysis. In step one, theoretically and/or data-driven control variables (e.g., NA, 
medical variables) were entered. In step two, the PA subscale was entered. For 
Hypothesis 2.1, the outcome variables were log mean diurnal cortisol, log mean waking 
cortisol, and log mean bedtime cortisol, respectively. For Hypothesis 2.2, the outcome 
variable was diurnal cortisol slope.  
Hypothesis 2.3 was explored using path analysis. The primary model included the 
exogenous variables of PA (PANAS-PA) and endogenous variables of mean diurnal 
cortisol and diurnal cortisol slope. All statistical assumptions were met prior to analysis. 
Secondary exploratory models were constructed to assess the contribution of control 
variables and CES-D PA, similar to the Hypotheses 1 and 2 regressions. The model 
parameters were reviewed, and model fit was assessed. Adjustments to improve model fit 
were addressed.   
Power analysis.  G*Power version 3.1.3 was used to determine the power of the 
enrollment sample size (N = 61) for the study aims. Voogt et al. (2005) found a small to 
medium effect of age (r = -.32) on PA in their sample of 105 mixed cancer patients. 
There was a medium effect of gender (Cohen’s d = .48, women had higher PA) and small 
effect of income (Cohen’s d = .19, higher income associated with more PA). The authors 
found a small effect of medical variables: length of disease in months (r = .06), planned 
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surgery (Cohen’s d = .87), planned chemotherapy (Cohen’s d = .06), planned radiation 
(Cohen’s d = .36). Increased physical functioning was positively associated with PA (r = 
.26). A small effect size of stage on PA (r = -.04) was found in a sample of 133 lung 
cancer patients (Hirsch, Floyd, & Duberstein, 2012). Based on the expectation of a small 
to medium effect size in our sample of 61, our power will range between .33 and .99 for 
Aim 1. 
Previous studies note a small to medium effect size for the relationship between 
PA and cortisol.  Polk et al. (2005) found small effect of .12 for the association of PA and 
reduced waking cortisol concentration in their sample of 334 healthy adults. They also 
noted a small effect of PA on diurnal slope (r = -.04 for trait PA, r = .10 for state PA; 
Polk et al., 2005). Another study of 166 healthy adolescents showed a small but 
significant effect of PA on steeper diurnal cortisol slope (β = -.04) and a significant 
medium to large effect size on lower bedtime cortisol (β = -.661; Hoyt et al., 2015). 
Miller et al. (2016) found a small but significant effect of PA on steeper diurnal cortisol 
slope  (β = -.19) in their sample of 490 healthy adults. In a breast cancer sample (N = 29), 
Giese-Davis, DiMiceli et al. (2006) found a small to medium effect of  .38 for the 
association of PA expression and reduced mean cortisol. The authors found no effect of 
PA expression on diurnal cortisol slope (r = -.01) but found a medium effect size on 
lower 8:00AM cortisol (r = -.33; Giese-Davis, DiMiceli et al., 2006). Based on the 
expectation of a small to medium effect size on cortisol measures in our sample of 61, 
our expected power ranged between .19 and .85 for Aim 2.  






 Patient Characteristics 
 Patient demographics are presented in Table 2.  Medical variables of the patient 
sample are presented in Table 3 (staging and diagnosis), Table 4 (medications), Table 5 
(smoking history), and Table 6 (cancer treatment). 
Aim 1 
 Hypothesis 1.1. Descriptive statistics were used to understand the overall 
distribution of positive affect. Table 7 presents the descriptive statistics of the items and 
summary scores for the PANAS and the positive items of the CES-D. Patients reported 
moderate PA (PANAS: M = 28.79, SD = 8.57, range = 11 – 47). The distributions of the 
PANAS PA subscale and the individual PA items appeared normal, with the exceptions 
of “proud”, which was more uniform in distribution, and “inspired”, which had a slight 
positive skew. On the PANAS, the most endorsed positive emotion was “Determined” (M 
= 3.31, SD = 1.15), and the least endorsed positive emotion was “Inspired” (M = 2.59, 
SD = 1.24). The CES-D PA subscale was negatively skewed, W(59) = .908, p < .001, 
with most people reporting moderate to high levels of PA (M = 8.57, SD = 2.98, range = 
1 – 12). The most common positive emotions endorsed on the CES-D were “I enjoyed 
life” and “I felt just as good as other people” (M = 2.31), while the least endorsed item 
was “I feel hopeful about the future” (M = 1.81). The distribution of PANAS PA and NA 
item means is shown in Figure 3.  
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A paired samples t-test tested the hypothesis that patients would report more PA 
than NA. The PANAS NA subscale was positively skewed, W(61) = .923, p = .001, while 
the PA subscale was normally distributed, W(61) = .985, p = .661; however, differences 
between the scores were computed and checked for normality using the Shapiro-Wilk 
test. The distribution of the differences between the PA and NA scores was normal, 
W(61) = .988, df = 61, p = .828, thus no assumptions were violated. The Shapiro-Wilk 
test of normality was used as it has higher power than the Kolmogorov-Smirnov test 
(Ghasemi & Zahediasl, 2012). Results indicated that, on average, patients experienced 
more PA (M = 28.79, SD = 8.57) than NA (M = 19.46, SD = 8.26), as measured by the 
PANAS. This difference, 9.33, 95% CI [6.52, 12.14], was significant t(60) = 6.633, p < 
.001, and represented a large effect, d = 1.12.   
Bivariate correlations explored whether the PA subscale of the PANAS related to 
the CES-D PA subscale.  The PANAS PA subscale was positively correlated with 
positive emotion (CES-D positive items, rs = .528, p < .001), which reflected a large 
effect size (Cohen, 1992). Although PANAS PA and CES-D were significantly correlated 
(thus risking multicollinearity), the CES-D was included in subsequent regression 
analyses (Aim 2) given that the correlation was less than .80 (Fields, 2013, p. 325).1  The 
PANAS PA and NA subscales were not significantly correlated (r = .138, p > .05).  
Summary of hypothesis 1.1 results. Hypothesis 1.1 was supported. Patients 
reported experiencing moderate levels of PA over the previous week. On average, they 
endorsed experiencing significantly more PA than NA. The PA subscales of the PANAS 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 CES-D was included in regression analyses also at the request of a committee reviewer 
at the time of the proposal review.  
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and CES-D were significantly correlated, providing construct validity. Last, the PA and 
NA subscales of the PANAS were not correlated, in line with previous literature.   
Hypothesis 1.2. Given the small sample size, the results of the EFA must be 
interpreted with caution. Some data suggests that 10-15 participants per variable is most 
reliable (Fields, 2012, p. 683); although, other research suggests a 3:1 participant-to-
variable ratio may be adequate enough to detect underlying factors (Anderson & Rubin, 
1956). Thus, with 61 participants and 20 variables (each of the 20 PANAS items), the 
available data meets a minimum requirement for an EFA. Kaiser-Meyer-Olkin measure 
of sampling adequacy (KMO) for this sample suggested an adequate and acceptable 
sample size (KMO = .734). Furthermore, communalities prior to extraction ranged from 
.556 - .856, again suggesting data were adequate to explore underlying factor structure.  
An initial check of correlations between items was conducted to examine data for 
extreme levels of multicollinearity (r > .8) and singularity (r = 1). No correlation 
exceeded r = .8. The highest item correlations were between active and determined (r = 
.742, p < .001) and scared and afraid (r = .757, p < .001). Bartlett’s test confirmed that 
the correlation matrix contained acceptable levels of correlations between variables (χ2 
(190) = 761.605, p < .001). All 20 PANAS items were therefore used in the EFA. Output 
was sorted by loading size, and factor loadings were not suppressed by loading size. 
EFA was conducted using Principal Axis Factoring. The first extraction was 
based on Kaiser’s rule and eigenvalues greater than 1. Since missing data had already 
been imputed and given the small sample size, pairwise case exclusion was selected to 
minimize any loss of data. Although theoretical and objective data from this sample 
suggest that PA and NA are independent and distinct dimensions, an oblique rotation 
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using promax criterion was conducted due to the exploratory nature of this analysis 
(Costello & Osborne, 2005). Oblique rotation allows for the potential for underlying 
factors to be correlated or uncorrelated, whatever best fits the data. Thus, if the 
underlying factors were indeed uncorrelated in this sample, a largely orthogonal solution 
would nevertheless emerge, despite using an oblique rotation method.  
 Using the eigenvalue greater than 1 criterion, the EFA extracted five factors. Of 
variance accounted for by these factors, factors 1 and 2 explained the most (29.8% and 
23.1%, respectively), while factors 3 through 5 explained much less (8.0%, 5.9%, 5.6%, 
respectively). The scree plot (Figure 4) demonstrated points of inflexion at the third, 
fourth, and sixth factors, suggesting a two, three, or five factor solution may be most 
appropriate for the data. These three solutions were therefore explored more thoroughly 
by re-running the analyses with forced cut-off criteria of two, three, and five factor 
solutions.  
Two-factor solution.  In the two-factor solution, all 20 PANAS items fell into the 
same PA and NA subscales as identified on the standardized measure. The pattern matrix 
(Table 8) revealed PA items strongly loaded onto factor 2 (coefficients ranged from .441 
- .816) and not factor 1 (coefficients ranged from -.230 - .152), while NA items strongly 
loaded onto factor 1 (coefficients ranged from .326 - .827) and not factor 2 (coefficients 
ranged from -.184 - .148).   Consistent with previous bivariate correlations, the 
intercorrelation matrix indicated that these PA and NA factors were mildly positively 
correlated (r = .12). The factor plot demonstrates that all PA and NA items strongly load 
onto two factors representing the respective PA and NA subscales of the PANAS (Figure 
5).  
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Three-factor solution. In the three-factor solution, all 10 PA items remained a 
cohesive factor, with coefficients ranging from .422 to .802. The PA items with the 
highest coefficients (>.7) were strong, proud, inspired, determined, attentive, and active. 
The pattern matrix (Table 9) showed that the NA items fell into two factors, with shame 
and guilt emotions emerging as a separate factor from the other items (factor 3; 
coefficients of .873 and .694). These two factors were moderately positively correlated (r 
= .336).  The PA factor remained mildly correlated with the NA factor (r = .113) and the 
shame/guilt factor (r = .135). The three-dimensional factor plot provides a visual 
representation of the three-factor solution (Figure 6).  
Five-factor solution. In the five-factor solution, the pattern matrix (Table 10) 
showed that items most strongly loaded onto the first four factors, suggesting the five 
factor solution is least parsimonious. In this solution, PA items fell into two factors, with 
excited and enthusiastic emerging as a separate factor (factor 4; coefficients of .682 and 
.583). The other PA items remained loaded together (factor 2; coefficients ranged from 
.358 - .866). The PA items with the highest coefficients (>.7) were determined, attentive, 
active, and strong. The NA items remained divided into two factors of general NA (factor 
1; coefficients ranged from .606 to .882) and shame/guilt (factor 3; coefficients of .647 
and .927).  The PA factors were moderately correlated to each other (r = .502), but were 
uncorrelated to the other factors (all r’s <  .10).  
Summary of hypothesis 1.2 factor analysis. Overall, the factor analysis remained 
consistent with previous literature that indicates that PA and NA are separate and distinct 
constructs. Using oblique rotation, the PA items consistently grouped together and 
remained uncorrelated to NA items.  The two-factor solution explained the large majority 
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of the variance of the model and aligned exactly with the previously validated PA and 
NA subscales of the PANAS measure. The three-factor solution suggested that feelings 
of shame and guilt may be uniquely experienced in a lung cancer sample, separate from 
other negative emotions. Similarly, based on the five-factor solution, feelings of 
excitement and enthusiasm may be experienced differently than other positive emotions 
among lung cancer patients.  
 Hypothesis 1.3. Associations with the PANAS. Associations with higher positive 
affect were explored through correlations with demographic, diagnosis and staging, 
smoking history, and treatment variables. Positive affect was significantly correlated with 
race (rs = -.265, p = .039), such that African American patients endorsed higher positive 
affect than White patients. Positive affect was not correlated with gender, years of 
education, or income.  
PA was not correlated with diagnosis and staging variables (age at diagnosis, time 
since diagnosis, stage, whether they had a comorbid medical condition). Positive affect 
was not correlated to current medications.  Of the smoking history variables, PA was 
negatively correlated to years smoking (the longer the patient smoked, the less PA; r = -
.296, p = .028).  
Of the cancer treatment variables, PA was correlated with current chemotherapy 
treatment, such that patients endorsed less PA if they were currently in treatment (rs = -
.374, p = .004). Similarly, having received chemotherapy in the past two months was 
correlated with lower PA, but at a trend level (rs = -.246, p = .068). Positive affect was 
not correlated to overall endorsement of ever receiving chemotherapy or with any 
radiation therapy variables.    
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Overall, some support for hypothesis 1.3 was found with the PANAS. Some 
variables indicating higher disease burden (longer smoking history, current or recent 
chemotherapy) were related to lower PA. Patients who endorsed significantly lower PA 
were White patients, those with a long history of smoking, and those who were currently 
receiving chemotherapy. African American patients, those who had smoked for fewer 
years, and those who were not currently in chemotherapy endorsed higher PA.  
Post-hoc analyses explored which PA items were potential drivers of the 
significant correlations observed with the PA subscale as a whole.  Six PA items were 
significantly related to race: strong (rs = -.423, p = .001), attentive (rs = -.395, p = .002), 
determined (rs = -.368, p = .004), active (rs = -.356, p = .005), inspired (rs = -.315, p = 
.013), and interested (rs = -.238, p = .037). Three PA items were significantly related to 
number of years smoking: active  (r = -.377, p = .005), alert (r = -.303, p = .024), and 
determined (r = -.293, p = .030). Six PA items were significantly related to current 
chemotherapy status: enthusiastic (rs = -.351, p = .006), inspired (rs = -.346, p = .007), 
strong (rs = -.334, p = .010), determined (rs = -.320, p = .013), interested (rs = -.313, p = 
.016), and active (rs = -.307, p = .018).  
 Associations with CES-D PA. The CES-D PA subscale showed a mostly similar 
pattern, with a few key differences. Again, race was associated with PA, with African 
Americans endorsing higher PA (rs = -.227, p = .033). Post-hoc item level analysis 
showed that race was significantly correlated (in the same direction) with two items: 
feeling just as good as other people (rs = -.295, p = .023) and enjoying life (rs = -.358, p = 
.005). Gender, education, and income were not associated with CES-D PA.   
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Again, CES-D PA was not correlated with diagnosis and staging variables (age at 
diagnosis, time since diagnosis, stage, whether they had a comorbid medical condition). 
However, while no medications were associated with PANAS PA, use of 
benzodiazepines (rs = -.282, p = .030) and use of estrogen medications (rs = -.256, p = 
.050) were associated with lower CES-D PA. Post-hoc item level analysis revealed that 
benzodiazepine use was negatively related to three of the four items: feeling hopeful 
about the future (rs = -.284, p = .029), feeling happy (rs = -.333, p = .010), and enjoying 
life (rs = -.320, p = .013).   
Correlations between PA and smoking variables differed between the PANAS-PA 
and CES-D PA. Of the smoking history variables, CES-D PA was negatively correlated 
with current number of packs/week (r = -.604, p = .029) and cigarettes/day (r = -.606, p = 
.022), but not with number of years the patient smoked as with the PANAS-PA. Post-hoc 
item level analysis revealed that items of ‘feeling happy’ and ‘enjoying life’ were related 
to currently smoking fewer packs per week (happy: r = -.637, p = .019; enjoying life: r = 
-.817, p = .001) and fewer cigarettes per day (happy: r = -.585, p = .028; enjoying life: r =  
-.750, p = .002).  Lower number of current cigarettes per day was also correlated with 
“feeling just as good as other people” (r = -.563, p = .035). Other smoking variables were 
not significantly correlated to PA.  
Similar to the PANAS PA, patients who were currently in chemotherapy (rs = -
.412, p = .001) or had chemotherapy in the past two months (rs = -.386, p = .004) had less 
PA on the CES-D. Post-hoc item level analysis revealed that patients who were currently 
in chemotherapy or had chemotherapy in the past two months reported less hopefulness 
about the future (current: rs = -.343, p = .008; past two months: rs = -.307, p = .023) and 
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enjoying life less (current: rs = -.497, p < .001; past two months: rs = -.358, p = .007). 
CES-D PA was not correlated to overall endorsement of ever receiving chemotherapy or 
with any radiation therapy variables.  
Overall, some support for hypothesis 1.3 was again found with the CES-D. 
Higher PA was experienced among African American patients and those not currently or 
recently in chemotherapy treatment. In particular, current or recent chemotherapy 
treatment was correlated with less hopefulness and less enjoyment of life. Positive affect 
was also associated with smoking variables, but captured different aspects than the 
PANAS. Current smoking behaviors, not years of overall smoking, were related to PA. 
Patients smoking less (packs/week, cigarettes/day) reported higher PA, and in particular 
endorsed being happier and enjoying life more.  The CES-D PA also appeared to relate to 
medication use, while the PANAS PA did not. Patients not taking benzodiazepines or 
estrogen medication reported higher PA on the CES-D. 
Summary of hypothesis 1.3 results. Associations with the PANAS and CES-D 
both showed that African American race and not currently being treated with 
chemotherapy predicted higher PA. Nuances in the relationship between PA and 
medications and smoking history emerged between the two measures.  Use of 
benzodiazepine and estrogen were associated with lower CES-D PA, but were not related 
to PANAS PA. Patients who smoked less (historically, as captured by PANAS PA, or 
currently, as captured by CES-D) endorsed higher PA. Taken together, higher PA seems 
to be associated with African American race, no current chemotherapy treatment, and 
smoking less.  
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Aim 2 
Data-driven covariates of cortisol outcomes. A description of cortisol variables 
is presented in Table 11. Correlation analyses tested significance of potential covariates 
of cortisol variables to be selected for use in analyses of Aim 2 hypotheses. Potential 
covariates included gender, race, age of diagnosis, stage, years of education, income, time 
since diagnosis, total pack years, current corticosteroid use, and current chemotherapy.  
Raw mean waking cortisol had no significant correlates. Raw mean bedtime cortisol was 
correlated at a trend level with whether the patient was currently receiving chemotherapy 
treatment (rs = .248, p = .068). Log mean waking cortisol did not significantly correlate 
with any variables. Log mean bedtime cortisol significantly correlated with age at 
diagnosis (r = .322, p = .014) and number of years smoking (r = .299, p = .033). Log 
mean diurnal cortisol correlated at the trend level with stage (rs = .241, p = .071). Cortisol 
slope was not significantly correlated with any covariates. Only the significant correlates 
for each cortisol outcome were used as control variables (covariates) in data-driven 
models for hypotheses 2.1 and 2.2. Thus no data-driven covariates were used for 
regressions with log mean diurnal cortisol, log mean waking cortisol, or cortisol slope. 
Data-driven covariates were only used for log mean bedtime cortisol regressions (i.e., age 
at diagnosis and number of years smoking) (Kraemer et al., 2001). 
All independent variables were centered prior to regression analysis (Kraemer & 
Blasey, 2004). Continuous variables were centered to their median. Dichotomous 
independent variables were coded as −1/2 and +1/2. Ordinal variables were coded as 
deviations around their median values, and categorical variables with m response options 
were dummy coded into −1/m and 1–1/m (e.g., −0.25 and 0.75) instead of 0 and 1. 
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For each regression conducted, the data were first explored for violations of 
assumptions of linearity, homoscedasticity, normal distribution of residuals, and absence 
of collinearity. Among all variables, no significant outliers were noted or removed, and 
relationships were deemed to be linear.  Assumptions of linearity and normal distribution 
of residuals were met for all regressions. In all regressions, missing cases were removed 
pairwise to maintain power.  
 Hypothesis 2.1. Mean Diurnal Cortisol. Hierarchical linear regressions tested the 
association between PA and mean diurnal cortisol. The first regression analysis did not 
necessitate any data-driven covariates and revealed that PANAS-PA was not associated 
with mean diurnal cortisol (p > .05; Table 12).  
A second regression analysis included theoretically-driven covariates (Step 1; 
PANAS-NA and corticosteroid use) and PANAS-PA (Step 2; Table 13). Corticosteroid 
use was significantly associated with mean diurnal cortisol (p = .043); PANAS-NA and 
PANAS-PA were non-significant (p > .05).  
A third regression analysis tested the association of both PANAS-PA and CES-D 
PA (no covariates) with mean diurnal cortisol also revealed no significant associations (p 
> .05; Table 14).  
A final regression analysis included theoretically-driven covariates (Step 1; 
PANAS-NA, corticosteroid use) and PA independent variables (Step 2; PANAS-PA, 
CES-D PA; Table 15). Corticosteroid use was associated with mean diurnal cortisol at a 
trend level (p = .062); no other covariates or independent variables were significantly 
associated with mean diurnal cortisol (p > .05).  
    
 57 
Waking Cortisol. Hierarchical linear regressions tested the association between 
PA and mean waking cortisol. The first regression analysis did not necessitate any data-
driven covariates and revealed that PANAS-PA was not associated with mean waking 
cortisol (p > .05; Table 16).   
A second regression analysis included theoretically-driven covariates (Step 1; 
PANAS-NA and corticosteroid use) and PANAS-PA (Step 2; Table 17). Corticosteroid 
was significantly associated with waking cortisol (p = .020); PANAS-NA and PANAS-
PA were non-significant (p > .05).  
A third regression analysis tested the association of both PANAS-PA and CES-D 
PA (no covariates) with mean waking cortisol. The analysis revealed that higher CES-D 
PA was associated with lower mean waking cortisol at a trend level (β = -.292, p = .053), 
while PANAS-PA was not associated with waking cortisol (p > .05; Table 18).). 
A final regression analysis included theoretically-driven covariates (Step 1; 
PANAS-NA, corticosteroid use) and PA independent variables (Step 2; PANAS-PA, 
CES-D PA; Table 19). Corticosteroid use was associated with mean waking cortisol (β = 
-.295, p = .030), and CES-D PA significance fell to a trend-level (β = -.269, p = .080). No 
other covariates or independent variables were significantly associated with mean waking 
cortisol.  
Bedtime Cortisol. Hierarchical linear regressions tested the association between 
PA and mean bedtime cortisol. The first regression analysis included data-driven 
covariates (Step 1; age at diagnosis, years smoking) and PANAS-PA (Step 2) and 
revealed that no variables were significantly associated with mean bedtime cortisol (p’s > 
.05; Table 20).  
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A second regression analysis included theoretically-driven covariates (Step 1; 
PANAS-NA, corticosteroid use), data-driven covariates (Step 1; age at diagnosis, years 
smoking) and the PANAS-PA (Step 2; Table 21). Corticosteroid was significantly 
associated with mean bedtime cortisol (p = .020); PANAS-NA and PANAS-PA were 
non-significant (p > .05).  
A third regression analysis testing the association of data-driven covariates (Step 
1; age of diagnosis, years smoking) and both PANAS-PA and CES-D PA (Step 2) with 
mean bedtime cortisol again revealed that no variables were significantly associated with 
mean bedtime cortisol (p > .05; Table 22).  
A final regression analysis included theoretically-driven covariates (Step 1; 
PANAS-NA, corticosteroid use), data-driven covariates (Step 1; age at diagnosis, years 
smoking), and PA independent variables (Step 2; PANAS-PA, CES-D PA; Table 23). 
Again, no variables were significantly associated with mean bedtime cortisol and no 
models were significant overall (p’s > .05).  
Hypothesis 2.2. Diurnal Cortisol Slope. Hierarchical linear regressions tested the 
association between PA and diurnal slope. The first regression analysis did not 
necessitate any data-driven covariates and revealed that PA was not significantly 
associated with diurnal slope (p > .05; Table 24).   
A second regression analysis included theoretically-driven covariates (Step 1; 
PANAS-NA, corticosteroid use) and the PANAS-PA (Step 2; Table 25). All variables 
were non-significant (p > .05).  
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A third regression analysis testing the association of both PANAS-PA and CES-D 
PA (Step 1) with diurnal slope again revealed that no variables were significantly 
associated with slope (p > .05; Table 26).  
A final regression analysis included theoretically-driven covariates (Step 1; 
PANAS-NA, corticosteroid use) and PA independent variables (Step 2; PANAS-PA, 
CES-D PA; Table 27). Again, no variables were significantly associated with cortisol 
slope and no models were significant overall (p’s > .05).  
Post-hoc analyses: Exclusion of patients on corticosteroids. To check that 
inclusion of patients on corticosteroids did not bias regression outcomes, patients 
currently on corticosteroid regimen (n = 20) were excluded from the dataset. Correlations 
of demographic and medical variables with cortisol outcomes were repeated to assess for 
potential covariates again; no significant covariates of cortisol outcomes were identified. 
Thus, regressions were conducted first with no covariates. A second regression adjusted 
for NA. A third regression included CES-D PA with no covariates. A final regression 
included NA, as well as CES-D PA.   
 In line with findings from the full dataset, PA (PANAS or CES-D) was not 
significantly associated with overall diurnal cortisol, mean log waking cortisol, mean log 
bedtime cortisol, or diurnal slope in any model (all p’s > 0.5). PANAS-NA was also not 
significantly associated with overall diurnal cortisol, mean log waking cortisol, or mean 
log bedtime cortisol (all p’s > .05). One difference did emerge however: PANAS-NA was 
associated with diurnal slope at a trend level the model that included PANAS-PA (Table 
28), and this association became statistically significant in the model with both PANAS-
PA and CES-D PA (Table 29). In these models, having more NA was associated with 
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having a flatter (i.e., more disrupted) diurnal slope (Figure 14); however, the overall 
model remained non-significant.  
Hypothesis 2.3.  Data were prepared in order to meet all statistical assumptions 
prior to path analysis. Centered data were used for exogenous (predictor) variables in 
order to remain consistent with the multiple regressions previously conducted.  First, 
patients who did not have cortisol outcome data were excluded from the analysis (n = 4) 
in order to meet the criterion of having no missing data. Second, two participants had not 
completed the CES-D PA, thus their total scores were missing; however, they were not 
missing any other data points. Therefore, the overall mean CES-D PA value from the 
sample (then centered to the median) was imputed for these two data points.   
Path analyses were performed using Amos version 25. An initial path analysis 
was used to evaluate the hypothesized model that PA would more strongly relate to 
overall diurnal mean than to diurnal cortisol slope.  The purpose of this model was to 
compare the path coefficients (beta weights) between PA and mean diurnal cortisol as 
well as PA and diurnal cortisol slope in one simultaneous model. The primary hypothesis 
was that the relationship between positive affect and mean diurnal cortisol would be 
greater (higher absolute value of path coefficient) than the relationship between positive 
affect and diurnal cortisol slope. Standardized regression weights (β) are reported. In line 
with previous regression model hypotheses, it was expected that positive affect would be 
negatively associated with mean diurnal cortisol and positively associated with diurnal 
slope. 
Model 1. Model 1 is a path diagram of the predicted interrelationships between 
the basic variables of the hypothesized model (Model 1; Figure 7): the exogenous 
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variable was PANAS PA; the endogenous variables were mean diurnal cortisol and 
diurnal cortisol slope. Error terms were derived from the endogenous variables. Path 
analysis demonstrated that PA was not significantly associated with cortisol variables 
(mean diurnal cortisol: β = -.088, p = .507), diurnal cortisol slope: β = .080, p = .549). 
The error terms of the cortisol variables were not significantly correlated (r = -.19, p = 
.163).  
Fit indices of Model 1 were reviewed to assess the match between the model and 
the data. When the error terms of the cortisol variables were free to correlate, the Chi 
Square statistic had zero degrees of freedom (χ2 = .000, df = 0), thus the probability level 
could not be computed and model fit could not be assessed. However, when the error 
terms were fixed as uncorrelated, the Chi Square statistic showed a non-significant 
difference between the predicted covariance matrix and the actual covariance matrix 
(CMIN = 2.049, df = 1, CMIN/df = 2.049, p = .152). Yet, the model demonstrated overall 
poor fit to the data (CFI = .000; IFI = .432; RMSEA = .137; NFI = .280). No 
modification indices were suggested in order to improve model fit.  
This first model’s poor fit to the data and the non-significant p-values of the paths 
do not lend full support for the hypothesis. However, the hypothesis may be partially 
supported in that the absolute value of the beta weight for the association between PA 
and mean diurnal cortisol was indeed greater than that of the cortisol slope. Further, the 
beta weight was in the hypothesized direction for overall mean cortisol.. Therefore, 
although the paths did not reach significance, the findings may suggest that this model is 
underpowered.  
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Model 2. An exploratory second model with more observed variables was 
constructed, based on the previous multiple regression analyses (Model 2; Figure 8). 
Secondary predictive variables (control variables) were included in the model given the 
theory-driven relationships previously established: corticosteroid use and PANAS 
negative affect. It was hypothesized that corticosteroid use will be associated with both 
cortisol variables. It was hypothesized that negative affect will be associated with higher 
mean cortisol and disrupted (i.e., flattened, lower) slope values. Overall model fit and 
hypothesized associations within Model 2 were reviewed. 
Model 2 exogenous variables included positive affect (PANAS), negative affect, 
and corticosteroid use; endogenous variables were mean diurnal cortisol and diurnal 
cortisol slope. Error terms were derived from the endogenous variables. Path analysis 
demonstrated that PA was not significantly associated with cortisol variables (mean 
diurnal cortisol: β = -0.141, p = .268; diurnal cortisol slope: β = 0.081, p = .533). 
Negative affect was also not significantly associated with cortisol variables (mean diurnal 
cortisol: β = 0.071, p = .576; diurnal cortisol slope: β = 0.150, p = .247). Corticosteroid 
use was associated with lower overall cortisol mean (β = -0.274, p = .030), but not with 
diurnal slope (β = 0.165, p = .203).  
Fit indices of Model 2 were reviewed to assess the match between the model and 
data; the model demonstrated good fit to the data. The Chi Square statistic showed a non-
significant difference between the predicted covariance matrix and the actual covariance 
matrix (CMIN = 3.042, df = 3, CMIN/df = 1.014, p = .385). Other indicators also 
supported good model fit (CFI = .986; IFI = .996; RMSEA = .016), while one index 
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suggested less of a fit (NFI = .764). No modification indices were suggested in order to 
improve model fit.  
The absolute value of the beta weight for the association between PA and mean 
diurnal cortisol was again indeed greater than that of the cortisol slope in this model. 
Several associations were in the predicted directions: higher PA and lower NA were 
related to a pattern of lower mean cortisol. All other variables seemed to be associated 
with flattened slopes; although, NA and corticosteroid use seemed to be more strongly 
suggestive of flatter slopes than PA. The non-significance coupled with the near-zero 
beta weights prevents us from drawing any firm conclusions regarding PA’s relative 
associations to the cortisol variables. Thus, the hypothesis could not be firmly supported. 
However, the model did demonstrate better fit to the data than Model 1 and the beta 
weight from PA to mean cortisol increased strength from Model 1.  
Model 3. An exploratory third model was created to consider the relationship 
between CES-D PA and cortisol outcomes (Model 3; Figure 9). In line with previous 
regressions, this model included PANAS PA and NA, CES-D PA, and corticosteroid use 
as the exogenous variables, while mean diurnal cortisol and diurnal cortisol slope 
remained the endogenous variables. Overall model fit and hypothesized associations 
within Model 3 were reviewed. 
Path estimates were similar to those of Model 2. Path analysis demonstrated that 
PANAS PA was not significantly associated with cortisol variables (mean diurnal 
cortisol: β = -0.046, p = .718; diurnal cortisol slope: β = -0.013, p = .916). CES-D PA 
was also not significantly associated with cortisol variables (mean diurnal cortisol: β = -
0.192, p = .128; diurnal cortisol slope: β = 0.187, p = .142). Negative affect was also not 
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significantly associated with cortisol variables (mean diurnal cortisol: β = 0.030, p = 
.812; diurnal cortisol slope: β = 0.190, p = .136). Corticosteroid use was associated with 
lower overall cortisol mean (β = -0.252, p = .046), but not with diurnal slope (β = 0.139, 
p = .275).  
Fit indices of Model 3 were reviewed to assess the match between the model and 
data; the model demonstrated poor fit to the data. The Chi Square statistic showed 
significant difference between the predicted covariance matrix and the actual covariance 
matrix (CMIN = 19.866, df = 6, CMIN/df = 3.311, p = .003). Other indicators also 
suggested poor model fit (CFI = .210; IFI = .478; NFI = .390; RMSEA = .203). 
Modification indices suggested correlating PANAS PA and CES-D PA (MI = 11.205, Par 
Change = 10.672) as a way to improve model fit.  
When this modification was completed, the model demonstrated better fit to the 
data. The PANAS PA and CES-D PA were moderately, but significantly correlated (r = 
.447, p = .002). The Chi Square statistic showed a non-significant difference between the 
predicted covariance matrix and the actual covariance matrix (CMIN = 7.363, df = 5, 
CMIN/df = 1.473, p = .195). Other indicators also suggested improved model fit (CFI = 
.865; IFI = .914; NFI = .774; RMSEA = .092). No modification indices were suggested in 
order to improve model fit.  
In again partial support of the hypothesis, the absolute value of the beta weight for 
the association between PANAS-PA and mean diurnal cortisol was indeed greater than 
that of the cortisol slope.  Higher PA (CES-D and PANAS-PA) and lower NA seemed to 
be related to lower mean diurnal cortisol. All other variables seemed to be associated 
with flattened slopes. As previously noted however, the non-significance of the beta 
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weights prevents us from drawing any significant conclusions regarding PA’s relative 
associations to the cortisol variables. The model including CES-D PA did not 
demonstrate as good of a fit as the Model 2. As expected, correlating PANAS-PA and 
CES-D PA, improved model fit however. 
 Summary.  Hypotheses and overall findings (whether each hypothesis was 
supported) are presented in Table 30. PA seemed to have a stronger relationship to mean 
diurnal cortisol than to diurnal slope. Further, higher PA and lower NA seemed to be 
related to lower mean cortisol. Most variables seemed to be associated with flattened 
slopes, likely due to pre-existed cortisol dysregulation. Findings must be interpreted 



















 This dissertation explored the experience of positive affect, and its biological 
correlates, in a sample of non-small cell lung cancer patients.  The importance of 
understanding the emotional experiences of these patients cannot be underestimated. 
Indeed, cancer diagnosis and treatment may be met with sadness, grief, and anxiety. 
However, experiences of positive emotions and their underlying psychological processes 
must be better understood to capture the full authentic emotional experiences of lung 
cancer patients. This topic is drastically understudied in the current literature. Thus, the 
results of this study highlight the nature of positive emotions as well as the potential 
relationships to physiological pathways associated with a known prognostic feature 
among lung cancer patients – cortisol dysregulation. 
Capturing a snapshot of lung cancer patients served among the greater Louisville 
area, the patients of the current study were mostly female, White, in their late 50s to early 
60s, and had a high school education. Most patients (57.5%) had a household income of 
under $40K per year. The majority of these patients had an initial diagnosis of stage III or 
stage IV lung cancer and had been diagnosed about two years previously. Patients 
diagnosed with this stage and type of cancer typically have had poor prognosis; patients 
with stage III have a 5-year survival rate of 13-36%, while patients with IV have a 5-year 
survival rate of <1-10% (American Cancer Society, 2017).  As a somber representative of 
this poor prognosis, several patients passed away during the duration of this study. As 
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such, the patients in this current study were undergoing unique set of psychological and 
physiological stressors as they faced a potentially terminal illness. However, as 
highlighted in this work, the majority of these reported positive mood states, even more 
so than negative mood. In honoring the complexity of emotional experiences when facing 
lung cancer, this dissertation deeply explores the quality and correlates of these positive 
emotions, while delving into the science behind the mind-body interaction of positive 
affect and psychophysiology.  
Aim 1 Discussion: Experiencing Positive Affect 
Hypothesis 1.1. Aim 1 of the current study sought to understand the frequency 
and quality of PA among lung cancer patients. By exploring elements of the person (e.g., 
demographic variables) and his or her cancer journey (e.g., medical variables), this aim 
helped to capture the patient experience of PA on an item, subscale, and construct level. 
Hypothesis 1.1 proposed that patients would experience moderate PA and would report 
more PA than NA, as tested by the PANAS. Hypothesis 1.1 was supported.  
Patients experienced moderate levels (scoring around 3 on a scale of 1-5) of PA. 
This finding highlights that patients did, in fact, experience PA while facing their cancer. 
As will be explored later, not only did the patients endorse actually experiencing positive 
mood, they reported having more positive than negative emotions over the past week in 
general. This endorsement of PA aligns with previous literature noting that, on average, 
most people endorse feeling neutral to positive emotions, rather than negative emotions 
(Diener & Diener, 1996).  The experience of PA among cancer patients is also not 
uncommon (Louro et al., 2015) and is the reason why it deserved scientific attention.  
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The consistency of this pattern among this sample highlights a potential normative 
experience of emotions overall, even in the face of cancer.  
A closer look at the most highly endorsed individual positive emotions revealed 
an interesting representation of the positive emotional states of these lung cancer patients, 
and captured a theme of overall resilience. On the PANAS, the most endorsed positive 
emotion was determined. In lung cancer patients, this may reflect psychological 
resilience and active approaches to coping and overcoming their cancer diagnosis. In 
other words, determined may reveal a “fighting spirit” coping strategy of these cancer 
patients, which reflects a tendency to actively confront and face cancer (Watson et al., 
1994).  In a study of 102 cancer patients, path analysis demonstrated that a fighting spirit 
was significantly associated with positive affect and was a partial mediator between 
optimism and positive emotions (Hodges & Winstanley, 2012). Determination in this 
sample may be revealed in the medical context as the patient being motivated to adhere to 
treatment, attend scheduled appointments, and even participate in this current research. 
(The latter of which may also reflect a potential sample bias.) In a psychological context, 
these patients’ determination may reflect a desire to live a full and meaningful life given 
the diagnosis of a potentially terminal illness. Determination may be a product or proxy 
of underlying resilient processes such as emotional flexibility, benefit finding, and post-
traumatic growth. More research is needed to elucidate the underlying processes 
contributing to this most commonly endorsed positive emotion in this sample. As such, 
further analyses using the fighting spirit subscale of the Mini-MAC (Mini Mental 
Adjustment to Cancer Scale; Watson et al., 1994) may elucidate the presence and extent 
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of fighting spirit and its association with other positive psychological processes in this 
sample.  
The other most highly endorsed PA items were alert and interested (Figure 3). 
Together, these three top PA items (determined, alert, interested) paint the picture of an 
engaged and resilient cancer patient. Again, in the medical context, someone with these 
features may be determined to fight his or her cancer by being alert and interested in the 
recommendations and treatment planning of his or her oncology team. Outside the 
medical setting, these three emotions may reflect a person who is present and engaged in 
their current life, by showing interest and alertness to meaningful activities and a 
determination to live life in a meaningful way in the face of a terminal illness.  
On the CES-D, the highest rated positive items were “I enjoyed life” and “I felt 
just as good as other people.” These again seem to reflect a sense of resilience: that these 
patients are still enjoying life and have maintained a sense of esteem despite lung cancer. 
This finding of feeling “just as good as other people” is interesting given the common 
experience of shame and self-blame associated with smoking among lung cancer patients 
(Else-Quest et al., 2009; LoConte et al., 2008). This is especially interesting as the 
current sample was made up of almost entirely patients who had a history of smoking or 
currently smoke. Of course, it is difficult to know how these patients understood and 
interpreted the term “good”. It may be that these patients engaged in cognitive flexibility 
about how to enjoy life despite their physical and emotional symptoms, which in turn led 
them to feel just as good as others without medical conditions. Conversely, given the high 
frequency of smoking in Kentucky, perhaps patients were comparing themselves to their 
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peers or family members, who also smoke, thus removing much of the stigma and 
allowing them to find commonality among other people.  
The least endorsed positive emotion on the PANAS was inspired. Inspiration 
denotes creating something new or having the urge to do or feel something. After a 
diagnosis of lung cancer, these patients may not be feeling inspired to make large 
changes in life (start new projects, etc.), but rather to enjoy what they have already. 
Consistent with this, the least endorsed positive emotion on the CES-D was feeling 
hopeful about the future. Again, these patients are facing a sobering reality of the poor 
prognosis of lung cancer. Therefore the lack of inspiration and hope may not necessarily 
be pessimism, but rather, realism.  
PA vs. NA. Patients reported experiencing more overall PA than NA, and there 
was a large effect size. This finding is similar to other previous research indicating that 
cancer patients do indeed tend to report more PA than NA (Louro et al., 2015). Among 
lung cancer patients, this finding may be surprising given that these patients also tend to 
endorse more distress than other cancer samples (Brintzenhofe-Szoc et al., 2009; Linden 
et al., 2012; Zabora, BrintzenhofeSzoc, Curbow, Hooker, & Piantadosi, 2001). However, 
it appears that the current set of patients is also experiencing normative, and high, levels 
of positive emotions, as seen in other cancer samples (Louro et al., 2015). 
On the other hand, one may also consider that this finding could reflect the 
tendency for people to avoid experiencing negative emotions – either by actively pushing 
them away or denying their presence in general – or to judge themselves for feeling 
negative emotions (David, 2017; Hayes, Strosahl, & Wilson, 2012). The endorsement of 
PA and relative lack of NA in the sample may be a reflection of either false positivity, 
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false non-negativity, or perhaps both. While we cannot say for certain whether the 
patients are engaging in active denial of negative emotions and/or falsely inflating their 
perception of their own positive mood states, it remains important to take this human 
tendency into consideration while interpreting the results of the study.  
As expected, the PA measures (PANAS-PA and CES-D PA) were positively 
correlated, which also reflected a strong effect size. Their strong correlation offers 
convergent construct validity for positive affect in this sample. Similarly, as seen in other 
samples, the PA and NA subscales of the PANAS were not correlated, offering 
discriminant validity to the measure. As suggested by previous studies, the current data 
again suggests that PA and NA are two distinct constructs (e.g., Watson, Clark, & 
Tellegen, 1988). With both convergent and discriminant validity of the PANAS PA, it 
can be assumed that this measure is indeed capturing what we hoped to explore in the 
current study – the experience of positive emotions.  
 Hypothesis 1.2. The second hypothesis of Aim 1 proposed that positive and 
negative affect items will emerge as separate factors in an exploratory factor analysis. 
Hypothesis 1.2 was supported.  The factor analysis most strongly suggested a two-
factor solution (Figure 4); although, three and five factor solutions also warrant attention. 
In the two-factor solution, the PA and NA factors emerged separately in the factor 
analysis, again indicting that they are separate and unique constructs. The two-factor 
solution demonstrated that the items fell into the respective PA and NA subscales of the 
standardized measure, offering support that the measure is valid among a sample of lung 
cancer patients.  
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Interestingly, in the three-factor solution, shame and guilt separated out from the 
NA subscale, suggesting that these two negative emotions may be experienced differently 
in the lung cancer sample. Among lung cancer patients, the experience of shame and guilt 
often relates to smoking history and the stigma associated with lung cancer (Else-Quest et 
al., 2009; LoConte et al., 2008). The finding that these two emotions emerged separately 
in this sample seems to highlight the uniqueness of these emotions among lung cancer 
patients. Given that all but two patients in the sample were either past or current smokers, 
it is likely that smoking history may relate to the separation of shame/guilt from other 
negative emotions in this sample. Future analyses may explore the unique contribution of 
these negative emotions in psychophysiological pathways.  
In the five-factor solution, excitement and enthusiasm separated out from the other 
positive emotions. Compared to the other positive affect items on the PANAS, these two 
emotions reflect a more active valence, which may not well suited to the diagnosis (i.e., 
functional ability).  The other positive items (i.e., strong, determined, attentive, 
interested, etc.) seem to fit better with a mindset of facing cancer as they may reflect a 
slightly less active valence.  
Overall, the factor analysis validated that PA and NA exist as separate constructs 
in this sample.  Further, a lack of negative emotion does not necessarily indicate a 
presence of positive emotion, and vice versa. Instead, these emotions may exist together 
in a dialectical relationship within the patient; distress and positive emotions can exist 
together (Folkman & Moskowitz, 2000). That is, the patient may be scared and nervous, 
but also feels strength and determination. As such, controlling for the effects of NA in the 
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subsequent regression analyses remained an appropriate method for elucidating the 
relative contributions of these separate emotional experiences.   
Hypothesis 1.3.  The third hypothesis of Aim 1 explored what demographics 
would be associated with higher PA and specifically proposed that lower disease burden 
(e.g., lower stage, no current treatment, longer time since diagnosis) would be associated 
with higher PA. Hypothesis 1.3 was partially supported.  
In considering demographic variables, African Americans endorsed more PA than 
White patients. Among seminal happiness studies, research shows that African 
Americans and European Americans typically endorse nearly the same levels of overall 
happiness and life satisfaction (Myers & Diener, 1995). Thus in this sample, a unique set 
of resilience factors may have contributed to this difference between races. Interestingly, 
a closer look at the PA items revealed that “strong” was most significantly correlated 
with race (i.e., African Americans endorsing “strong” more so than White patients). 
Research suggests that African Americans endorse more meaning/peace and faith when 
facing a chronic illness (including cancer), when compared to White or Latino 
counterparts (Peterman et al., 2002). African American breast cancer patients also report 
utilizing religious coping more so than non-Hispanic White patients (Culver et al., 2002). 
Other unique coping strategies of African American cancer patients include developing a 
positive attitude and avoiding negative people, having a will to live, and receiving a 
variety of social support (Henderson et al., 2003). Therefore, there are unique cultural 
factors to be further explored about the meaning of “strength” and its multidimensional 
qualities in the context of cancer. In this sample, strength may be differentially 
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interpreted as physical, emotional, spiritual, or social strength, depending on unique 
coping strategies associated with ethnicity.  
 Among medical variables, the first finding was that a higher number of years 
smoking was negatively correlated to PA, especially items of “active”, “alert”, 
“determined”. The first two terms may reflect behaviors associated with smoking, such as 
sedentary behavior (Strine et al., 2005). A person who has smoked for fewer years may 
more highly endorse feeling determined, which may reflect quitting earlier or being 
determined to reduce smoking. The CES-D PA (i.e., feeling happy, enjoying life) was 
negatively associated with current number of packs per week and cigarettes per day, but 
was not correlated with historical factors of smoking. Taken together, current smoking 
habits seem to relate to emotional experiences related to engaging in life and feeling 
happy, while history of smoking (i.e., years smoked) seem to relate to emotional 
experiences that may more strongly reflect health-behavior type PA items (active, alert, 
determined).  
Second, current chemotherapy was negatively associated with PA, especially 
items of “enthusiastic”, “inspired”, “strong”, “determined”, “interested”, and “active”. 
Patients currently undergoing chemo are typically much more physically ill because of 
side effects, so these findings are not surprising. On the CES-D, chemotherapy (current 
and in the past two months) was negatively associated with enjoying life and feeling 
hopeful about the future. Of course, chemotherapy requires frequent and lengthy 
appointments at cancer treatment sessions for infusions, thus the large amount of time 
spent in the hospital coupled with the difficult side effects would naturally make it very 
difficult to enjoy life on a daily basis. However, because these items also correlated with 
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chemotherapy status two months prior, these findings seem to capture some of the longer-
term associations with treatment on mood and quality of life. Undergoing chemotherapy 
serves as a stark reminder of the gravity of cancer, which may decrease patients’ 
hopefulness about the future in the immediate timing around that treatment as well as 
several months after.  
Other medical factors were not associated with PA, including cancer stage. 
Similar to national averages, the majority (66%) of the patients in this sample were stage 
III (n = 26) or IV (n = 14), with 23% of the sample being metastatic, thus limiting the 
variance based on stage. This limited variance may have masked any differences in mood 
based on stage.   
In this sample, age at diagnosis may not have related to PA since the majority of 
patients were older in age when they were diagnosed. There is a known preservation and 
even increase of positive emotions with advancing age (Mroczek & Kolarz, 1998), 
partially explained by improved emotion regulation over the lifespan (Carstensen, 1991; 
Carstensen, 1995). Therefore, this known effect of age and positive emotion may 
override any effects of age at diagnosis related to PA, given that age at study enrollment 
and age at diagnosis were relatively similar and both later in life (61 vs. 59 years old). 
Further, time since diagnosis may not have related to PA given that many of the patients 
have not been recently diagnosed (i.e., within the past several months), thus any acute 
effects on mood may have dissipated over time. Sixty percent of patients were diagnosed 
in the past two years, with only seven patients being diagnosed in the past three months. 
The lack of correlation between time since diagnosis and PA reflects the work of Duh, 
Diener, and Fuhita (1996), who discovered that life events (good or bad) only affected 
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happiness if they occurred in the previous two months. Thus the overall lack of 
correlation between certain medical/demographic characteristics may reflect emotional 
rebound that occurs after major life events (Diener, Lucas, Scollon, 2006). 
Aim 2 Discussion: Positive Affect and Cortisol 
Aim 2 focused on understanding the relationship between PA and diurnal cortisol 
among the sample.  In order to better understand the diurnal patterns of the current 
sample and aid in discussion, several descriptive graphs were made post-hoc. Figure 10 
shows the raw mean waking and bedtime cortisol values to create a graphic 
representation of the overall diurnal slope. Graphically, the diurnal slope indeed shows a 
descending pattern, indicating some maintenance of HPA rhythm. However, slope 
change of raw cortisol scores of less than approximately 0.2 µg/dL is conventionally 
considered flattened or aberrant (Sephton et al., 2000; Sephton et al., 2013). The overall 
raw slope change observed in this sample (0.17 µg/dL) and demonstrated in Figure 10 is 
nearly identical to the flattened pattern observed in a previous study of cortisol and early 
mortality in lung cancer (Sephton et al., 2013). As such, Figure 10 suggests an overall 
flattening of diurnal slope in this sample, despite a general decline from morning to 
evening raw values. 
   Figure 11 qualitatively demonstrates the average “steep” vs. “flattened” diurnal 
slope of the sample. In this figure, diurnal cortisol slope was split at the median slope 
value and log mean waking and bedtime values were again graphed. The variability 
among the waking the bedtime values among the steep and flattened slopes again 
suggests an overall disruption of the HPA in this sample.  
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To elucidate typical patterns observed in this sample, a third figure was created. 
Figure 12 demonstrates three representative patterns of diurnal slope from three patients 
in the sample: steep, flattened, and ascending. For descriptive purposes, relatively steep 
slopes were qualitatively and conservatively categorized as a decline of 0.20 µg/dL from 
raw waking to bedtime values; ascending were categorized as any increase from waking 
and bedtime. About 36% of patients showed steep slopes, 52% showed flattened slopes, 
and 13% had ascending slopes. These qualitative categorizations are similar to other 
cancer samples with disrupted rhythms (Sephton et al., 2000). Further, when compared to 
other cancer samples, patients in the current study seemed to have overall lower levels of 
diurnal cortisol and overall flatter slopes (Table 31; Abercrombie et al., 2004; Cash et al., 
2015; Sephton et al., 2013).    
Last, Figure 13 presents the raw mean waking and bedtime cortisol values for 
patients who were taking corticosteroids versus those who were not. The graph 
demonstrates that patients taking corticosteroids had lower raw waking values, thus 
potentially contributing to an overall flattening of the diurnal slope. Such an effect is 
consistent with research showing that corticosteroid use suppresses HPA activity 
(Chourous, Pavlaki, & Magiakou, 2011). 
The descriptive characterization of cortisol among the sample highlights the high 
level of disruption of HPA rhythms evident at baseline. Research shows that 30-70% of 
cancer patients display disruptions in diurnal cortisol rhythms, including uncoordinated 
or erratic peaks and nadirs throughout the day, phase shifts, or generally flattened 
patterns at either abnormally high or low levels (Sephton & Spiegel, 2003). Such patterns 
are most evident in patients with high tumor burden, poor performance status, and liver 
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metastases (Sephton & Spiegel, 2003). As such, disrupted cortisol rhythms may be an 
indicator of progressing tumor status or the result of other biological effects of worsening 
psychosocial functioning (e.g., poor sleep due to pain or anxiety; Eismann et al., 2003; 
Sephton & Spiegel, 2003). Further, use of systemic corticosteroids can disrupt cortisol 
levels through HPA suppression (Chourous, Pavlaki, & Magiakou, 2011). Thus, 
associations among positive affect and cortisol may have been masked by the overall 
disruption of the HPA at baseline, contributing disease-related variance that may have led 
to the overall lack of findings for Aim 2 in this study. 
 Hypothesis 2.1.  Aim 2 tested the relationships between positive affect and 
cortisol variables, and hypothesis 2.1 stated that higher PA would be related to lower 
mean cortisol levels. Hypothesis 2.1 was not supported.  
Higher CES-D PA was associated with lower waking cortisol at a trend level. No 
other significant findings or trends were observed with CES-D PA or PANAS PA and 
mean cortisol levels.  The CES-D PA finding remains interesting despite the other non-
significant findings. Perhaps the CES-D PA items serve to capture PA in a contextual 
sense. That is, CES-D may capture a sense of trait or even “lifestyle” positive affect – 
enjoying life, feeling as good as others, feeling happy, being hopeful about the future; 
while the PANAS-PA items don’t have as much of a sense of being placed in the context 
of life (e.g., hopeful about the future vs. just hopeful).  
Overall, higher PA was not related to overall mean diurnal cortisol, bedtime 
cortisol, or waking cortisol. Similarly, negative affect also did not show strong 
associations with cortisol means.  Again, the lack of findings (for both PA and NA) may 
be a result of the overall cortisol dysregulation already in place, masking any associations 
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with psychosocial variables. Instead, other factors may have played a larger role 
(behavior, tumor biology, medications) in cortisol levels. 
As expected, higher log mean bedtime cortisol significantly correlated with older 
age of diagnosis and more years of smoking. Also, raw mean bedtime cortisol was 
observed to be higher at a trend level when a patient was currently receiving 
chemotherapy treatment.  Research shows that elevated bedtime cortisol is observed 
among people with sleep disturbance and insomnia (Buckley and Schatzberg, 2005). 
Research affirms that about 30-50% of newly diagnosed or recently treated oncology 
patients report sleep disturbance and that this number is significantly higher than healthy 
controls (Savard & Morin, 2001). Among lung cancer samples, clinical insomnia may be 
present in about 30% of patients (Ginsburg et al., 1995; Sarna, 1993). Therefore, these 
trend-level findings may hint towards a mechanism of cancer-related insomnia.  
 Hypothesis 2.2.  The second hypothesis of Aim 2 stated that higher PA will be 
related to steeper diurnal cortisol slope. Hypothesis 2.2 was not supported.  In all 
regressions, PA was not associated with diurnal slope.  
However, when patients on corticosteroids were excluded from the sample, higher 
NA was associated with flatter cortisol slopes (Figure 14). This finding mirrors research 
demonstrating that depression is associated with flattened diurnal rhythms and disruption 
of the HPA (Spiegel & Giese-Davis, 2003). As presence of NA (and lack of PA) is a core 
feature of depression, it may be that NA (as a proxy of depressive symptoms) potentially 
masks the effects of PA on slope in this subsample. Or, it may be that the patients with 
higher NA were not experiencing sufficient levels of PA to combat depressive symptoms 
(Folkman & Moskowitz, 2000), thus leading to an association with biology. 
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Overall, the null findings regarding PA and slope in this sample may be a function 
of other (stronger) influences on cortisol, such as medications (corticosteroids), sleep, 
treatment effects, or tumor biology variables. Further, NA seemed to have a stronger 
relationship to slope, suggesting the known strong biological effects of depressive 
symptoms may mask contributions of PA on HPA function.  As suggested in the 
integrated model (Figure 1), eudaimonia and the experience of psychological well-being 
may be more effective than PA on cortisol outcomes due to synergy among multiple 
psychological resilience factors. The psychological resources of eudaimonia create 
emotional resilience that interacts with appraisal, coping, and/or emotional responses. 
This model is consistent with other stress-and-coping models of positive psychological 
resilience factors, such as mindfulness (Salmon, Sephton, & Dreeben, 2011). Cancer 
patients who demonstrate self-acceptance and have made meaning of their diagnosis may 
appraise stressors as less threatening and cope more efficiently, thus avoiding the 
biological disruption of chronic stress. Last, the null findings with cortisol slope may also 
relate to variability in PA (Human et al., 2015), as coping with cancer likely is met with a 
wide range of both positive and negative emotional experiences that may vary from day 
to day.  
Hypothesis 2.3.  The third hypothesis of Aim 2 used path analysis to test whether 
PA would more strongly relate to mean diurnal cortisol than to diurnal cortisol slope. 
Hypothesis 2.3 was partially supported.  In all three path analysis models, the beta 
weight between PANAS PA and mean diurnal cortisol was consistently stronger than that 
between PANAS PA and diurnal slope. Second, the beta weights were consistently in the 
negative direction, suggesting an underlying pattern that higher PA (PANAS and CES-D) 
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is associated with lower mean diurnal cortisol. These two points are in support of the 
hypotheses. However, the path estimations were not statistically significant, thus firm 
support of the hypotheses cannot be assumed. However, the findings support of the 
proposed integrated model that PA may work to have an undoing effect on mean diurnal 
cortisol, yet may need to be in conjunction with other resilience factors to more strongly 
associate with robust cortisol slopes. The consistency of the direction and strength of the 
beta weights among the models suggest that further investigation may be fruitful. The 
lack of statistical significance but consistency in hypothesized direction of the path 
estimates may suggest that the study is underpowered and that these pathways may reach 
significance in a larger sample. Further, the fact that all of the predictor variable seemed 
to be associated with flattened slopes again highlights that pre-existed cortisol 
dysregulation may be present in the sample. 
The models from the path analysis reflected the findings from the individual 
regression analysis (beta weights remained consistent between analyses). However, the 
benefit of these models is that they allow us to consider the effect of mood on both 
cortisol variables at the same time. Model 1 presented the most simple path analysis, 
using only the primary variables of interest. The model demonstrated poor fit, likely due 
to the fact that PA did not relate strongly to either of the cortisol variables and explained 
only a small portion of the variance in mean cortisol and cortisol slope. Fit improved 
however when other variables were added to the path diagram, suggesting that these 
elements help explain the cortisol variables.  
Model 2 demonstrated the best overall fit of all of the models. All but one index 
suggested good fit, with the exception of NFI. However, NFI tends to underestimate fit in 
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small sample sizes, such as in this current study, which likely explains why it differed 
from the other more robust fit indicators (Iacobucci, 2010). This again builds the case that 
this current study may be underpowered for these analyses.  
In Model 3, the CES-D PA variable demonstrated a stronger relationship (i.e., 
higher absolute value of beta weights) to the cortisol variables than the PANAS-PA. This 
is consistent with the regression analyses of Aim 2. Although again these paths did not 
reach statistical significance, it seems worthy to consider how the CES-D PA items may 
be capturing positive psychological processes that are different, albeit correlated, to those 
reflected in the PANAS-PA. Or, perhaps, the CES-D PA items mask the effects of the 
PANAS-PA because they are highly correlated. That is, the CES-D items may capture a 
superordinate positive psychological process that may mask the effects of the positive 
affective states of the PANAS-PA. For example, a recent study on hedonia and 
eudaimonia in ovarian cancer patients utilized structural equation modeling and found 
that eudaimonia was associated with lower tumor norepinephrine, while PA was not, 
despite the high correlation between eudaimonic well-being and PA (Davis et al., 2015). 
Models 2 and 3 included PANAS NA. In both of these models, association 
between NA and diurnal slope was stronger than between NA and mean diurnal cortisol 
and between PA and diurnal slope. Although these paths were not statistically significant, 
it may be possible that NA accounts for more variance in diurnal slope, thus masking any 
effect of PANAS PA.  






There are several limitations to the current study to be considered.  As previously 
mentioned, the study may have been underpowered to capture the nuanced relationships 
between positive affect and biology. The relatively small sample size keeps us from 
drawing large conclusions based on the findings. Further, the study did not include a 
comparison group of healthy controls upon which to compare the nature of PA as well as 
the potential relationships with the HPA.  
Second, the study captured a sample that was mostly female, non-Hispanic White 
patients, of lower socio-economic status. While this cohort of patients deserves attention, 
the sample demographics limit the generalizability of the finding to more diverse patient 
groups, in regard to gender, race, and income. Importantly however, since much research 
is conducted among breast cancer patients/survivors, this current sample had relative 
strength in including both male and female patients.   
The current study had an enrollment criterion of having a diagnosis within the 
past five years. However, five years time offers a wide range of psychological 
experiences for patients. Newly diagnosed patients may have a radically different 
emotional experience than those who are several years since diagnosis or early treatment. 
Given this wide range of time and potentially different stages of coping among the 
patients, associations among psychosocial and physiological factors may have been 
masked by disease-related variance.  
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 Last, this study relied on self-report for all psychological measures. As with any 
self-reported variable, one runs the risk of hindsight bias, variations in mood, and overall 
difficulty in capturing true representation of an emotional experience. Further, the study 
was limited to the positive affect measures that were included at the outset of the study, 
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FUTURE DIRECTIONS 
Many researchers note that the field would greatly advance from more research on 
PA and neuroendocrine function, particularly among unhealthy samples (e.g., Chida & 
Steptoe, 2008; Davis et al., 2015; Howell et al., 2007).  Several avenues of future 
research may improve the quality of research and address several points derived from this 
current work. First, studies should seek to include broad measures of PA – both hedonic 
and eudaimonic – to be able to deeply explore the quality and outcomes of these complex 
emotional experiences among cancer patients. Studies should seek to use similar and 
standardized measures of PA and consistent terminology. Clarification of whether PA 
measured is state or trait will also help to untangle short-term versus long-term 
associations with biology, and will help parse out potential overlap with confounding 
variables. Positive affect measurements and study designs should also seek to elucidate 
the role of arousal and PA variability (Hoyt et al., 2015; Human et al., 2015). Underlying 
mechanisms of positive mood, such as the fighting spirit, adaptive coping, and social 
support, may render fruitful avenues for broadening the understanding of positive 
psychological processes in mind-body medicine. 
Similarly, close attention to subtypes of positive mood may seem to play a 
particularly important role in physical well-being. In particular, a recent large-scale study 
(N = 5,554) found that low PANAS PA was significantly associated with mortality, and 
this finding was equally as strong among cancer-related and cardiovascular-related deaths 
(Petrie et al., 2018). Importantly, the PANAS PA item “active” largely explained this 
finding (Petrie et al., 2018).  Given that “active” was significantly associated with 
smoking and chemotherapy status in this sample, future research may explore the role of 
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sedentary behavior and its physical and mental effects among lung cancer patients. 
Overall, the relationship between specific positive emotions and modifiable health 
behaviors in the context of cancer prevention and control warrants greater attention. 
Second, future studies should employ reliable cortisol calculation and collection 
methods and report on multiple cortisol outcomes. Such rigor may highlight differential 
pathways and mechanisms, and clarify the relationships between overall secretion, slope, 
and CAR, and related clinical outcomes.  The use of standardized collection times and 
measures will help to reduce variation between study designs, and will facilitate more 
reliable cross-study comparisons. 
Third, future studies should seek to enroll larger, diverse samples, with a 
comparison group of healthy controls. Such studies may wish to focus on a certain time 
point since diagnosis (e.g., within months as opposed to years) to capture more specific 
associations between mood and biology. Future studies may also benefit from using 
ecological momentary assessment to capture a more accurate picture of the patients’ 
positive mood states, as well as their variability within-person.  
Fourth, more studies should also be conducted within the lung cancer population. 
The vast majority of cancer research, and all of the current PA and cortisol research 
among cancer samples, is among breast cancer patients. Given the implications for 
coping, meaning-making, and resilience factors, the field would benefit from research in 
highly distressed cancer populations, such as lung cancer.  Building this body of research 
lends practical utility in psychological and medical care domains, and highlights the 
importance of granting cancer patients greater access to psychologists. Future 
psychosocial interventions for cancer patients may seek to promote authentic and realistic 
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experiences of PA, while simultaneously building psychological resources to create 
eudaimonic well-being. Research on mindfulness-based therapies shows that this may be 
a promising avenue for linking PA, eudaimonia, and cortisol (Jimenez, Niles, & Park, 
2010; Tang et al., 2007).  
Fifth, in considering the roles of NA and PA, special attention must be paid to 
confounding effects of syndromal and subsyndromal depression. Such symptoms 
commonly co-occur in cancer patients (Spiegel & Giese-Davis, 2003). Importantly, 
depression has prognostic significance among lung cancer patient (Pirl et al., 2012), and 
even subclinical levels can be associated with early mortality in cancer (Zimmaro et al., 
2017). Depression is characterized not only by presence of NA, but lack of PA (Folkman 
& Moskowitz, 2000; Radloff, 1977). Depression also has known associations with HPA 
dysregulation (Currier & Nemeroff, 2014). Therefore, future studies should carefully 
ensure analyses control for the effects NA when testing the associations of PA with 
cortisol in cancer patients. Further, special attention should be made to the experiences of 
shame and guilt in this population, given that these experiences may be qualitatively 
different among different cancer types. Future studies may also wish to utilize the ratio of 
positive to negative affect (Critical Positivity Ratio; Fredrickson & Losada, 2005) as 
deeper exploration of the relationship between positive and negative emotions within this 
population.  
Last, future research should continue to explore the proposed pathways of the 
integrated model outlined at the outset (Figure 1). Direct effects should first be examined. 
Moderators of the model should also be tested, with particular attention to individual 
difference factors and cancer-related variables. Mediational analyses might examine the 
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neurobiological pathways of hedonia and eudaimonia in cancer patients, especially 
pathways that involve the HPA. Controlled experiments could explore the undoing and 
buffering hypotheses as outlined in the model. Last, the clinical significance of cortisol 




























The blossoming research on positive psychology is making its way into policy on 
a national and global scale, and indeed this progress is moving into the healthcare field.  
In 2015, the World Health Organization launched a series of Sustainable Development 
Goals, aimed to increasing health and well-being on a global scale (World Health 
Organization, 2016).  However, specific efforts within the cancer field have yet to be 
established, allowing for large-scale opportunities of growth in this area.  
 This current research highlighted that while typically lung cancer patients are 
considered some of the most distressed cancer patients, they are also experiencing 
positive and resilient emotions. While the biological associations of these emotions may 
have been masked by tumor-relevant physiological disruption, the everyday experience 
of positive states may have considerably increased a patient’s quality of life. In the face 
of a terminal illness, it may not be the quantity of life that matters the most, but rather, 
the quality of the days left.  




Table 1  
 

























Four PA adjectives, 




on each day of data 
collection. Items were 










samples/day, at two 
timepoints:1) three 
consecutive days one 
month prior to 
mammogram, 2) day 
before, day of, and day 
after procedure. 
Measures were 
average cortisol level, 
diurnal slope, and 
cortisol reactivity 
(slope change score 





























PA expression during 
therapy session; PA 
expression included 
affection (verbal and 
touch), interest, 
validation, accurate 
   
Hedonic, state 
(may also be 
trait if 
expression is 
thought of as 
personality 
trait) 
Salivary; 4 samples 
per day (8:00, 12:00, 
17:00, 21:00h), for 3 
consecutive days. 
Diurnal cortisol slope 
and mean cortisol level 

































PANAS, measured as 
state during Trier Social 
Stress Test (TSST) 
Hedonic, state Salivary; 5 samples 
per day (waking, 
+30mins, 12:00h, 
17:00h, 21:00h) for 2 
consecutive days, 1 
week prior to TSST 
and day after TSST. 10 
salivary samples 
throughout TSST. 
Diurnal slope, waking 
levels, CAR, and 
recovery levels of 
evening, next day 
waking and CAR 
(baseline levels minus 









and lower PA 













interview for 8 
consecutive days; rated 
frequency (5point scale) 
of 13 PA items 
experienced that day. 
Ratings were averaged to 
obtain overall PA 
measure.  
Hedonic, trait 
(average of 8 
days) 
Salivary; 4 samples 
per day (waking, 
waking+30mins, 
before lunch, before 
bed), for 4 consecutive 
days. Measures were 
diurnal slope, total 
output  (AUC), and 












with more PA, 
and less total 
cortisol. On 
stressor days, 

















Table 2  
Sample Demographics 







Gender Male 20 32.8 
Female 41 67.2 
Race Black or African 
American 
13 21.3 
White 48 78.7 
Education 
Completed 
Middle School (7-8 
years) 
4 6.6 
High School (12 years) 34 55.7 
AA/Technical (14 years) 16 26.2 
BA/BS (16 years) 4 6.6 
MA/MS (18 years) 3 4.9 
Income <$15,000 17 27.9 
%15,001-$19,999 5 8.2 
$20,000 - $29,999 9 14.8 
$30,000 -$39,999 4 6.6 
$40,000 - $49,000 7 11.5 
$50,000 - $59,999 1 1.6 
$60,000 - $69,999 6 9.8 
$70,000 - $79,999 1 1.6 
$80,000 - $89,000 2 3.3 
$90,000 - $99,999 1 1.6 
$100,000 - $149,999 4 6.6 
$150,000 - $249,999 1 1.6 
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Table 3 
Cancer Staging and Diagnosis Variables 





Age at diagnosis 58.97 
(8.76) 
Time since diagnosis (months) 22.28 
(17.32) 
Summary stage I 14 23 
II 7 11.5 
III 26 42.6 
IV 14 23 
Diagnosed with other medical 
condition 
No 18 29.5 
Yes 43 70.5 




Patients’ Current Medications  
 
Medication Type Frequency (n)  Percent of Sample (%) 
Adrenals 0 0 
Anti-convulsants 7 11.5 
Anti-depressants 15 24.6 
Anxiolytics 0 0 
Benzodiazepine 10 16.4 
Systemic Contraceptives 0 0 
Corticosteroids 20 32.8 
Estrogens 3 4.9 
Opiate Agonists 17 27.9 
Tranquilizers 0 0 
Sedatives/Tranquilizers 0 0 

































Smoking History  
 
Smoking Variable Mean (SD) Levels Frequency (n) Percent of 
Sample 
(%) 
History of Smoking 
(including current) 
 No 2 
 
3.3 
Yes 59 96.7 
Currently smoke 
cigarettes 
 No 44 72.1 
Yes 16 26.2 
 
Current Smokers (n=16) 
Current packs per week 3.12 (3.17)    
Current cigarettes per day  11.28 (8.91)    
How many years have you 
been smoking 
39.54 (15.24)    
 
Patients with a Smoking History (Including Current Smokers; n=59) 
History of smoking 
cigarettes  
 No 2 3.3 
Yes 59 96.7 
How many years did you 
smoke?  
36.11 (12.12)    
Years since quitting 
smoking 
8.08 (9.14)    
How many packs/week 
did you smoke? 
7.76 (4.93)    
How many cigarettes/day 
did you smoke? 
22.66 (12.94)    
Pack Years (Current) 
(packs/day x years 
smoking) 
20.00 (14.35)    
Pack Years (History) 42.07 (29.47)    
Total Pack Years 41.43 (30.05)    
 




Cancer Treatment Variables 
 
Variable Level Frequency 
(n) 
Percent of Sample 
(%) 
Have you ever received chemo? No 12 19.7 
Yes 48 78.7 
    
Are you currently receiving chemo? No 38 62.3 
Yes 21 34.4 
    
Have you received chemo in the past 2 
months? 
No 34 55.7 
Yes 22 36.1 
    
Have you ever received radiation? No 22 36.1 
Yes 38 62.3 
    
Are you currently receiving radiation? No 57 93.4 
Yes 3 4.9 
    
Have you received radiation in the past two 
months? 
No 50 82.0 



























Positive and Negative Affect Descriptives 
 
Scale Mean (SD) Score Range 
PANAS – Positive Affect Items   
          Interested 3.16 (1.05) 1-5 
          Excited 2.64 (1.08) 1-5 
          Strong 2.85 (1.11) 1-5 
          Enthusiastic 2.64 (1.17) 1-5 
          Proud 2.87 (1.43) 1-5 
          Alert 3.26 (1.14) 1-5 
          Inspired 2.59 (1.24) 1-5 
          Determined 3.31 (1.15) 1-5 
          Attentive 2.97 (1.13) 1-5 
          Active 2.93 (1.06) 1-5 
          PA Subscale Mean 2.92 (0.83) 1.10-4.70 
          PA Total Score 29.24 (8.30) 11-47 
   
PANAS – Negative Affect Items   
          Distressed 2.13 (1.06) 1-5 
          Upset 2.15 (1.18) 1-5 
          Guilty 1.46 (0.91) 1-5 
          Scared 2.10 (1.31) 1-5 
          Hostile 1.43 (0.83) 1-5 
          Irritable 2.38 (1.21) 1-5 
          Ashamed 1.40 (0.86) 1-5 
          Nervous 2.45 (1.35) 1-5 
          Jittery 2.11 (1.27) 1-5 
          Afraid 2.10 (1.43) 1-5 
          NA Subscale Mean 1.97 (0.82) 1-4 
          NA Total Score  19.71 (8.21) 10-40 
   
CES-D – Positive Items   
          Felt I was just as good as other people 2.31 (0.92) 0-3 
          Felt hopeful about the future 1.81 (1.04) 0-3 
          I was happy 2.14 (0.82) 0-3 
          I enjoyed life 2.31 (0.90) 0-3 
          CES-D Positive Items Mean 2.14 (0.74) 0.25–3.00 
          CES-D PA Total Score 8.57 (2.98) 1-12 
   








Two-Factor Pattern Matrix 
    Factor 
PANAS Items   1   2 
PA Items         
 interested   .152   .535 
 excited   .214   .441 
 strong   -.133   .748 
 enthusiastic   .011   .667 
 proud   -.141   .686 
 alert   .159   .623 
 inspired   -.230   .816 
 determined   .060   .725 
 attentive   .016   .770 
 active   .094   .758 
NA Items         
 distressed   .755   -.086 
 upset   .827   .058 
 guilty   .326   .131 
 scared   .694   -.025 
 hostile   .605   -.054 
 irritable   .742   -.184 
 ashamed   .370   .005 
 nervous   .748   .148 
 jittery   .702   .087 
 afraid   .826   .050 
Note.  Extraction Method: Principal Axis Factoring. Rotation Method: Promax with 








Three-Factor Pattern Matrix 
PANAS Items 
  Factor 
  1   2   3 
PA Items             
 interested   .542   .168   -.039 
 excited   .422   .112   .225 
 strong   .744   -.139   .007 
 enthusiastic   .673   .032   -.053 
 proud   .715   -.047   -.221 
 alert   .613   .107   .113 
 inspired   .802   -.292   .128 
 determined   .729   .074   -.036 
 attentive   .791   .081   -.149 
 active   .742   .017   .167 
NA Items             
 distressed   -.057   .862   -.195 
 upset   .075   .857   -.050 
 guilty   .066   .040   .694 
 scared   -.020   .676   .044 
 hostile   -.053   .576   .067 
 irritable   -.184   .701   .099 
 ashamed   -.091   .027   .873 
 nervous   .163   .769   -.037 
 jittery   .085   .658   .101 
 afraid   .051   .784   .093 
 
Note. Extraction Method: Principal Axis Factoring. Rotation Method: Promax with 
Kaiser Normalization. Item loadings are bolded for each appropriate factor.  
 
 




 Five-Factor Pattern Matrix  
PANAS 
Items 
  Factor 
  1   2   3   4   5 
PA items                     
 interested   .118   .358   -.073   .251   .326 
 excited   .051   -.012   .178   .682   .206 
 strong   -.182   .703   .008   .062   .311 
 enthusiastic   .051   .299   -.115   .583   -.048 
 proud   .002   .480   -.245   .350   -.156 
 alert   .151   .533   .126   .185   -.179 
 inspired   -.277   .579   .104   .348   -.001 
 determined   .087   .859   .011   -.153   .065 
 attentive   .107   .866   -.120   -.094   .038 
 active   .033   .844   .224   -.071   -.025 
NA  Items                     
 distressed   .882   .133   -.166   -.278   .024 
 upset   .871   .026   -.051   .103   -.051 
 guilty   .019   .045   .647   .146   .064 
 scared   .606   -.109   .003   .103   .483 
 hostile   .596   -.105   .072   .121   -.135 
 irritable   .765   -.093   .132   -.071   -.278 
 ashamed   .007   .028   .927   -.006   -.112 
 nervous   .718   .116   -.042   .067   .271 
 jittery   .626   .202   .128   -.139   .181 
 afraid   .734   -.157   .046   .313   .281 
 
Note. Extraction Method: Principal Axis Factoring. Rotation Method: Promax with 
Kaiser Normalization. Item loadings are bolded for the appropriate factor.  
 
 




Cortisol Variable Descriptives 
 
Cortisol Variable Mean (SD)  Range 
Raw Waking Cortisol (µg/dL) 0.289 (.133) 0.013 – 0.745 
Log Waking Cortisol, log(µg/dL) -1.553 (.756) -5.097 – -0.342   
Raw Bedtime Cortisol (µg/dL) 0.119 (.093) 0.011 – 0.447 
Log Bedtime Cortisol, log(µg/dL) -2.840 (.946) -5.841 – -1.190 
Log Diurnal Mean, log(µg/dL) -2.189 (.666) -4.738 – -1.168 
Diurnal Slope, log(µg/dL)/Hr -0.049 (.107) -0.257 – 0.305 
Raw Slope (µg/dL) 0.170 (.151) -0.18 – 0.63 
Note. Raw slope is the change score between raw bedtime and raw waking cortisol 



























PANAS-PA and Data-Driven Controls Regressed onto Mean Diurnal Cortisol  
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .008 .008   .433 .513 
PANAS-PA -.088 -.658 .513 -.088       











































PANAS-PA and Theoretically-Driven Controls Regressed onto Mean Diurnal Cortisol 
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .256 .064 .065 .161 1.889 .161 
PANAS-NA .044 .336 .738 .044       
Steroid -.253 -1.925 .060 -.253       
Step 2     .290 .084 .019 .301 1.626 .194 
PANAS-NA .064 .485 .630 .064       
Steroid -.276 -2.071 .043* -.272       
PANAS-PA -.141 -1.045 .301 -.137       






































PANAS-PA, CES-D PA and Data-Driven Controls Regressed onto Mean Diurnal 
Cortisol 
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .234 .055   1.506 .231 
PANAS-PA .019 .126 .901 .017       
CES-D-PA -.242 -1.607 .114 -.217       









































PANAS-PA, CES-D PA and Theoretically-Driven Controls Regressed onto Mean Diurnal 
Cortisol 
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .256 .065   1.819 .172 
PANAS-NA .044 .330 .743 .044       
Steroid -.253 -1.889 .065 -.253       
Step 2     .345 .119 .054 .229 1.688 .167 
PANAS-NA .012 .089 .929 .012       
Steroid -.258 -1.908 .062 -.253       
PANAS-PA -.035 -.223 .825 -.030       
CES-D PA -.216 -1.404 .167 -.186       




































PANAS-PA and Data-Driven Controls Regressed onto Waking Cortisol  
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .057 .003   .178 .675 
PANAS-PA -.057 -.422 .675 -.057       











































PANAS-PA and Theoretically-Driven Controls Regressed onto Waking Cortisol  
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .300 .090   2.672 .078 
PANAS-NA .028 .214 .831 .029       
Steroid -.300 -2.308 .025* -.300       
Step 2     .320 .102 .012 .401 2.011 .124 
PANAS-NA .044 .334 .739 .044       
Steroid -.318 -2.409 .020* -.314       
PANAS-PA -.113 -.847 .401 -.116       






































PANAS-PA, CES-D PA and Data-Driven Controls Regressed onto Waking Cortisol  
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .265 .070   1.960 .151 
PANAS-PA .071 .477 .635 .064       
CES-D-PA -.292 -1.934 .053 -.259       










































PANAS-PA, CES-D PA and Theoretically-Driven Controls Regressed onto Waking 
Cortisol 
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .300 .090   2.573 .086 
PANAS-NA .028 .210 .834 .028       
Steroid -.300 -2.264 .028* -.300       
Step 2     .395 .156 .066 .152 2.311 .070 
PANAS-NA .021 -.153 .879 -.020       
Steroid -.295 -2.232 .030* -.290       
PANAS-PA .019 -.127 .900 .016       
CES-D PA -.269 -1.786 .080 -.232       




































PANAS-PA and Data-Driven Controls Regressed onto Bedtime Cortisol 
 
Variable β t p sr R R2 ΔR2 
p 
(ΔR2) F p 
Step 1     .359 .129   3.545 .037* 
Age at Diagnosis .230 1.472 .148 .198       
Years Smoking .182 1.167 .249 .157       
Step 2     .359 .129 .000 .973 2.315 .088 
Age at Diagnosis .229 1.432 .159 .195       
Years Smoking .184 1.100 .277 .150       
PANAS-PA .005 .035 .973 .005       





































PANAS-PA and Theoretically-Driven Controls Regressed onto Bedtime Cortisol  
 
Variable β t p sr R R2 ΔR2 
p 
(ΔR2) F p 
Step 1     .397 .158   2.154 .089 
Age at 
Diagnosis 
.028 1.608 .115 .218       
Years Smoking .015 1.202 .236 .163       
PANAS-NA .012 .745 .460 .101       
Steroid -.285 -1.050 .299 -.142       
Step 2     .398 .159 .001 .814 1.699 .154 
Age at 
Diagnosis 
.029 1.607 .115 .220       
Years Smoking .014 1.041 .303 .142       
PANAS-NA .012 .766 .448 .105       
Steroid -.295 -1.063 .293 -.145       
PANAS-PA -.004 -.237 .814 -.035       































PANAS-PA, CES-D PA and Data-Driven Controls Regressed onto Bedtime Cortisol  
 
Variable β t p sr R R2 ΔR2 
p 
(ΔR2) F p 
Step 1     .359 .129   3.545 .037* 
Age at 
Diagnosis 
.230 1.472 .148 .198       
Years Smoking .182 1.167 .249 .157       
Step 2     .373 .139 .010 .760 1.857 .134 
Age at 
Diagnosis 
.223 1.384 .173 .189       
Years Smoking .197 1.163 .251 .159       
PANAS-PA .059 .364 .717 .050       
CES-D PA  -.114 -.743 .461 -.102       


































PANAS-PA, CES-D PA and Theoretically-Driven Controls Regressed onto Bedtime 
Cortisol 
 
Variable β t p sr R R2 ΔR2 
p 
(ΔR2) F p 
Step 1     .397 .158   2.154 .089 
Age at 
Diagnosis 
.257 1.608 .115 .218       
Years Smoking .189 1.202 .236 .163       
PANAS-NA .103 .745 .460 .101       
Steroid -.143 -1.050 .299 -.142       
Step 2     .404 .163 .005 .873 1.427 .226 
Age at 
Diagnosis 
.255 1.527 .124 .211       
Years Smoking .186 1.082 .285 .149       
PANAS-NA .089 .596 .554 .082       
Steroid -.141 -1.001 .322 -.138       
PANAS-PA .005 .028 .978 .004       
CES-D PA -.075 -.466 .643 -.070       





























PANAS-PA and Data-Driven Controls Regressed onto Diurnal Cortisol Slope  
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .080 .006   .353 .555 
PANAS-PA .08 .594 .555 .080       











































PANAS-PA and Theoretically-Driven Controls Regressed onto Diurnal Cortisol Slope  
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .230 .053   1.509 .230 
PANAS-NA .116 1.250 .217 .166       
Steroid .154 1.164 .250 .154       
Step 2     .245 .060 .007 .536 1.24 .348 
PANAS-NA .153 1.139 .260 .152       
Steroid .168 1.244 .219 .166       
PANAS-PA .085 .623 .536 .083       






































PANAS-PA, CES-D PA and Data-Driven Controls Regressed onto Diurnal Cortisol 
Slope  
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .163 .027   .709 .497 
PANAS-PA .010 .062 .950 .009       
CES-D-PA .158 1.038 .304 .142       









































PANAS-PA, CES-D PA and Theoretically-Driven Controls Regressed onto Diurnal 
Cortisol Slope 
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .230 .053   1.453 .243 
PANAS-NA .166 1.227 .225 .166       
Steroid .154 1.142 .259 .154       
Step 2     .301 .091 .038 .361 1.247 .303 
PANAS-NA .203 1.432 .158 .193       
Steroid .151 1.099 .277 .148       
PANAS-PA -.015 -.095 .925 -.013       
CES-D PA .204 1.303 .199 .181       




































Exclusion of Patients on Corticosteroids: PANAS-PA and Theoretically-Driven Controls 
Regressed onto Diurnal Cortisol Slope 
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .302 .091   3.613 .065 
PANAS-NA .302 1.901 .065 .302       
Step 2     .304 .093 .001 .818 1.786 .183 
PANAS-NA .295 1.805 .080 .292       
PANAS-PA .038 .232 .818 .037       







































Exclusion of Patients on Corticosteroids: PANAS-PA, CES-D PA and Theoretically-
Driven Controls Regressed onto Diurnal Cortisol Slope 
 
Variable β t p sr R R2 ΔR2 p (ΔR2) F p 
Step 1     .302 .091   3.512 .069 
PANAS-NA .302 1.874 .069 .302       
Step 2     .377 .064 .051 .387 1.822 .162 
PANAS-NA .379 2.170 .037* .350       
PANAS-PA -.085 -.457 .651 -.074       
CES-D PA .261 1.380 .177 .222       
























Hypotheses and Findings Summary 
 
Hypothesis  Finding 
Aim 1 Understand the frequency and quality of PA among 
lung cancer patients 
 
     1.1 Patients will experience moderate PA and will report 
more PA than NA. 
Supported 
     1.2 Positive and negative affect items will emerge as 
separate factors. 
Supported 
     1.3 Variables that reflect lower disease burden will be 
associated with higher PA.  
 
Partially Supported 
Aim 2 Test the relationship between positive affect and 
cortisol variables 
 
     2.1 Higher PA will be related to lower mean cortisol 
levels. 
Not Supported1  
     2.2 Higher PA will be related to steeper diurnal cortisol 
slope. 
Not Supported2  




Note. Superscript indicates significant or trend findings for relevant hypothesis.   1 Higher 
CES-D PA was associated with lower waking cortisol at a trend level. 2 Higher NA was 
associated with flatter slopes when not including patients on corticosteroids.   3 Absolute 
values and direction of beta weights were in hypothesized directions, but did not reach 
























Comparison of Cortisol Variables to Other Research Samples 
 
Cortisol Variable Cortisol Mean (SD) in Comparative Samples 














































      
Note. NR = not reported. Lung cancer sample statistics are from Sephton et al., 2013. 
Breast cancer sample statistics are from Cash et al., 2015. Metastatic breast cancer 
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Figure 1. An integrated model of PA and cortisol in cancer patients. Lettered arrows 
indicate processes and relationships. Arrow A: Cancer is associated with psychological 
distress (stress). Arrows B and C: Stress influences the areas of the cortex, limbic system, 
and HPA, which interact to result in the release of cortisol (total cortisol level, diurnal 
slopes, CAR; Arrow D). Arrows E and F: Neuroimaging literature indicates that PA and 
eudaimonia influence brain structures involved in regulating HPA system. Arrow G: PA 
encourages eudaimonia in cancer through the Broaden and Build Theory. Arrow H: 
Based on the Undoing Hypothesis, patients’ PA undoes effects of acute stress on the 
HPA (H1), leading to a lower total cortisol levels and reactivity (H2). Arrow I: Based on 
the Buffering Hypothesis, eudaimonia buffers effects of chronic stress through building 
psychological resources (I1), influencing more robust cortisol outcomes like diurnal 
slopes. Arrows J and K: Neuroendocrine and immune processes interact to influence 















Figure 2. Hypothesized relationships for current study. Figure demonstrated proposed 
pathways to be tested in a sample of lung cancer patients. Pathway to be tested is adapted 
from arrow H2 from Figure 1. Hypothesis 1 states that positive affect will be associated 
with lower mean cortisol variables. Hypothesis 2 states that positive affect will be 












Figure 3.  Mean score for each positive and negative affect item on the PANAS. Scores 
reflect the extent to which patients felt each of the emotions over the past week. Each 
item was endorsed on a 1-5 Likert scale of very slightly or not at all to extremely. Item 
means are presented in descending order. Solid bars represent the positive affect items; 
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Figure 4. Scree plot from factor analysis of PANAS items. Scree plot demonstrates 
points of inflexion (bolded dots) at the third, fourth, and sixth factor numbers, suggesting 






























Figure 5.  Factor plot in rotated factor space showing two-factor solution.  PANAS PA 
and NA items strongly loaded onto the respective PA and NA subscales identified on the 
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Figure 6.  Factor plot in rotated factor space showing three-factor solution.  PANAS PA 
items remained as their own factor (open circles). NA items fell into two factors, with 
NA items of “ashamed” and “guilty” loading independently onto a separate factor (red 
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Figure 7.  Model 1 path analysis. Standardized regression weights are displayed on 
arrows from PANAS PA to cortisol variables. Squared multiple correlations are displayed 
above the endogenous variables. The correlation between the error terms is displayed on 










Figure 8.  Model 2 path analysis. Standardized regression weights are displayed on 
arrows from control variables (glucocorticoid use, PANAS NA) and PANAS PA to 
cortisol variables. Squared multiple correlations are displayed above the endogenous 
variables. The correlation between the error terms is displayed on the double arrow. 
Glucocorticoid use was negatively associated with mean diurnal cortisol (p = .030); no 
other relationships were statistically significant. 
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Figure 9.  Model 3 path analysis. Standardized regression weights are displayed on 
arrows from control variables (glucocorticoid use, PANAS NA) and PANAS PA to 
cortisol variables. Squared multiple correlations are displayed above the endogenous 
variables. The correlation between the error terms is displayed on the double arrow. 
Glucocorticoid use was negatively associated with mean diurnal cortisol (p = .046); no 
other relationships were statistically significant.  




Figure 10. Raw mean (error bars show standard deviation) diurnal salivary cortisol levels 
(µg/dl) at waking and bedtime for overall sample. Mean diurnal slope for the sample 
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Figure 11. Raw mean (error bars show standard deviation) diurnal salivary cortisol levels 
at waking and bedtime for two groups of patients split at the median diurnal slope (-0.05 
log (µg/dl)/Hr). Mean slope for flat slope group (n=28) was 0.028 log(µg/dl)/Hr and for 
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Figure 12.  Raw mean diurnal salivary cortisol levels at waking and bedtime for three 
study participants with representative cortisol profiles observed: flattened descending 
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Figure 13. Raw mean salivary cortisol levels at waking and bedtime, split by patients 
who were taking corticosteroids versus those who were not. Patients on corticosteroids 
appear to have lower mean morning values; although, cautious interpretation is 
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Figure 14. Raw mean (error bars show standard deviation) diurnal salivary cortisol levels 
at waking and bedtime for two groups of patients split at the median NA score (NA = 
18). Patients in this figure are not taking corticosteroids (n = 41). The group with less NA 
(n = 20, M = 12.15) had steeper slopes (-0.094 log(µg/dl)/Hr) than the group with more 
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epilepsy. Poster presentation at the annual meeting of the American Epilepsy Society, 
San Diego, CA. 
10. Sepeta, L.N., Xu, B., Berl, M.M., Zimmaro, L.A., D’Alfonso, A., Theodore, W.H., 
Gaillard, W.D. (2012, December). Hippocampal functioning in children and adults 
with epilepsy. Poster presentation at the annual meeting of the American Epilepsy 
Society, San Diego, CA. 
11. * Rebholz, W.N., Weissbecker, I., Cash, E., Bayley R., Zimmaro, L., Sephton, S.E. 
(2014, March). Distress and support: links with circadian disruption and quality of 
life in gynecologic cancer. Paper presentation at the American Psychosomatic 
Society 72nd Annual Scientific Conference, San Francisco, CA.  
12. Bayley, R.C., Dedert, E., Rebholz, W.N., Cash, E., Zimmaro, L.A., Salmon, P., 
Sephton, S.E. (2014, March). Recent traumatic events may complicate adjustment to 
gynecologic cancer. Poster presentation at the American Psychosomatic Society 72nd 
Annual Scientific Conference, San Francisco, CA.  
13. Zimmaro, L.A., Cash, E., Dedert, E., Rebholz, W.N., Bayley, R.C., Salmon, P., 
Sephton, S.E. (2014, March). Distress, coping, and support in lung cancer: Gender 
differences and associations with psychopathology. Poster presentation at the 
American Psychosomatic Society 72nd Annual Scientific Conference, San Francisco, 
CA. 
14. * Sephton, S.E., Cash, E., Chagpar, A., Spiegel, D., Rebholz, W.N., Bayley, R.C., 
Zimmaro, L.A., and Dhabhar, F.S. (2014, March). Biological correlates of marital 
status in recently diagnosed breast cancer patients. Paper presentation at the 
American Psychosomatic Society 72nd Annual Scientific Conference, San Francisco, 
CA. 
15. Croft, L.J., Baldeweg, T., Sepeta, L., Zimmaro, L.A., Berl, M.M., Gaillard, W.D. 
(2014, June). Vulnerability of the ventral language network in children with focal 
epilepsy. Poster presentation at the 11th European Congress on Epileptology, 
Stockholm, Sweden.  
16. Rebholz, W.N., Weissbecker, I., Cash, E., Bayley-Veloso, R., Zimmaro, L.A., 
Phillips, K., Sephton, S.E. (2015, March). Diurnal cortisol rhythms and systemic 
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norepinephrine predict gynecologic cancer survival. Poster presentation at the 
American Psychosomatic Society 73rd Annual Scientific Conference, Savannah, GA. 
17. Bayley-Veloso, R., Weissbecker, I., Rebholz, W.N., Cash, E., Zimmaro, L.A., 
Phillips, K., Salmon, P., Sephton, S.E. (2015, March). Do traumatic events build 
resilience and promote survival through social support in gynecologic cancer? 
Poster presentation at the American Psychosomatic Society 73rd Annual Scientific 
Conference, Savannah, GA. 
18. Zimmaro, L.A., Rebholz, W.N., Cash, E., Bayley-Veloso, R., Phillips, K., Salmon, 
P., Sephton, S.E. (2015, March). Optimism as a moderator of psychoneuroimmune 
pathways in lung cancer patients. Poster presentation at the American Psychosomatic 
Society 73rd Annual Scientific Conference, Savannah, GA. 
19. * Cash, E., Chilton, P., Rebholz, W.N., Bayley-Veloso, R., Zimmaro, L.A., 
Chagpar, A.B., Spiegel, D., Dhabhar, F.S., Sephton, S.E. (2015, March). HPA and 
rest/activity rhythms independently associate with different aspects of inflammatory 
response in patients awaiting treatment for breast cancer. Paper presentation at the 
American Psychosomatic Society 73rd Annual Scientific Conference, Savannah, GA. 
20. Phillips, K., Salmon, P., Patel, H., Rowe, J., Rebholz, W.N., Zimmaro, L.A., 
Bayley-Veloso, R., Cash, E., Giese-Davis, J., Sonnier, H., Sephton, S.E. (2015, 
March). The role of mindfulness in stress and health outcomes in university 
undergraduate students. Poster presentation at the American Psychosomatic Society 
73rd Annual Scientific Conference, Savannah, GA. 
21. Zimmaro, L.A., Sephton, S.E. (2015, July). Psychophysiological pathways of fatigue 
in lung cancer patients. Poster presentation at the World Congress on Psycho-
Oncology (International Psycho-Oncology Society & American Psychosocial 
Oncology Society), Washington, DC.  
22. Hicks, A.M., Salmon, P., Phillips, K., Zimmaro, L.A., Siwik, C., Bayley-Veloso, R., 
Cash, E., Sephton, S.E. (2016, March). The Role of Mindfulness in Stress and 
Depression of Undergraduate Students. Poster presentation at the American 
Psychosomatic Society 74th Annual Scientific Conference, Denver, CO.  
23. Siwik, C.J., Phillips, K., Zimmaro, L.A., Bayley-Veloso, R., Hicks, A.M., Cash, E., 
Salmon, P., Sephton, S.E. (2016, March). Psychological and Physiological Effects of 
Problem-focused and Emotional Approach to Coping Styles in Gynecological Cancer 
Patients. Poster presentation at the American Psychosomatic Society 74th Annual 
Scientific Conference, Denver, CO.  
24. Phillips, K., Bayley-Veloso, R., Zimmaro, L.A., Siwik, C., Hicks, A.M., Cash, E., 
Salmon, P., & Sephton, S.E. (2016, March). Living situation and quality of life 
among cancer patients.  Poster presentation at the American Psychosomatic Society 
74th Annual Scientific Conference, Denver, CO. 
25. Zimmaro, L.A., Segerstrom, S., Cash, E., Siwik, C., Phillips, K., Rebholz, W., & 
Sephton, S. E. Moderating role of mindfulness on daily affect and cortisol in lung 
cancer patients. (2017, March).  Poster presentation at the American Psychosomatic 
Society 75th Annual Scientific Conference, Sevilla, Spain. 
26. Rebholz, W.N., Cash, E., Siwik, C., Phillips, K., Albert, C., Zimmaro, L.A., 
Dhabhar, F.S., Barve, S., Sephton, S.E. (2017, June). Pro-inflammatory, 
Chemotactic, and Anti-Inflammatory Cytokine Responses Associate with HPA, but 
not SNS, Function in Lung Cancer Patients. Poster presentation at 
Psychoneuroimmunology Research Society 24th Annual Meeting, Galveston, TX. 
27. Siwik, C., Rebholz, W., Phillips, K., Cash, E., Dhabhar, F.S., Barve, S., Zimmaro, 
L.A., Sephton, S.E. (2017, June). Sense of Coherence in Lung Cancer Patients: 
Association with Coping, Immune Function, and Fatigue. Poster Presentation at 
Psychoneuroimmunology Research Society 24th Annual Meeting, Galveston, TX. 
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28. Cash, E., Rebholz, W., Albert, C., Fields, O., Zimmaro, L.A., Siwik, C., Phillips, K., 
Sephton, S.E. (2017, June). Associations between the Prognostics Indicators 
Rest/Activity Rhythm and Diurnal Cortisol Profiles in Patients with Lung Cancer. 
Poster presentation at Psychoneuroimmunology Research Society 24th Annual 
Meeting, Galveston, TX. 
29. Sephton, S.E., Cash, E., Zimmaro, L.A., Rebholz, W.N., Albert, C., Fields, O., 
Siwik, C., Phillips, K. An iPod-based adaptation of MBSR for lung cancer: 
Associations of usage with depressive symptoms and behavioral and endocrine 
circadian markers. (2017, June). Poster presentation at Psychoneuroimmunology 
Research Society 24th Annual Meeting, Galveston, TX. 
30. * Carson, J.W., Olsen, M.K., Sanders, L., Keefe, F., Zimmaro, L.A., Porter, L.S. 
Greater mindfulness associated with lower pain, fatigue, and psychological distress 
in women with metastatic breast cancer. (2018, March). Paper Presentation at 
Society for Behavioral Medicine 39th Annual Meeting, New Orleans, LA.  
31. Sephton, S.E., Hicks, A., Phillips, K., Siwik, C., Albert, C., Zimmaro, L.A., van der 
Gryp, K.A., and Salmon, P. A brief iPod-based mindfulness intervention for 
undergraduates: Effects on psychological and physiological outcomes. Abstract 
submitted for consideration for presentation at the 75th annual meeting of the 
American Psychosomatic Society in Louisville, KY, March 7-10, 2018. 
32. Siwik, C., Segerstrom, S., Phillips, K., Cash, E., Rebholz, W., Zimmaro, L.A., Hicks, 
A., van 
der Gryp., K., & Sephton, S. E. Associations of Actigraphically Measured Daytime 
Sedentariness and Nighttime Restfulness with Waking and Bedtime Salivary Cortisol 
Levels. Abstract submitted to the American Psychosomatic Society 76th Annual 
Meeting, Louisville, KY.  
33.  Van der Gryp., K., Siwik, C., Zimmaro, L. A., Phillips, K., Rebholz, W., Cash, E., 
Hicks, A,., & Sephton, S. E. Lung cancer-related distress is associated with elevated 
mean diurnal cortisol levels. Abstract submitted to the American Psychosomatic 
Society 76th Annual Meeting, Louisville, KY.  
34. Phillips, K., Siwik, C., Segerstrom, S., Zimmaro, L. A., Rebholz, W., Cash, E., 
Hicks, A., van der Gryp, K., Sephton, S.E. Associations between daily affect, 
intrusive thoughts, and cortisol levels among lung cancer patients. Abstract submitted 
to the American Psychosomatic Society 76th Annual Meeting, Louisville, KY.  
35. Hicks, A., Salmon, P., Rebholz, W., Phillips, K., Siwik, C., Zimmaro, L.A., Cash, 
E., van der Gryp., K., & Sephton, S. E. The Role of Self-Compassion in a Stress-
Health Pathway. Abstract Submitted to the American Psychosomatic Society 
76thAnnual Meeting, Louisville, KY.  
 
Other Abstracts and Presentations  
1. Cheerharan, M., Blackstone, K., Zimmaro, L.A., Gaillard, W.D., & Berl, M.M. 
(2011, August). DTI of Working Memory in Pediatric Epilepsy Patients vs. Controls. 
Poster presentation at the George Washington University Medical School Research 
Day, Washington, DC. 
2. Fisher, E.L., Blackstone, K., Cayless, S., Zimmaro, L.A., Gaillard, W.D., Berl, 
M.M. (2011, April). Executive Functioning in Pediatric Epilepsy Population. Poster 
presentation at the ChildrenEpilepsy Population.  Medr Research Day, Washington, 
DC. 
3. Packer, T., Zimmaro, L.A., Cash, E., Sephton, S.E. (2014, September). Circadian 
disruption: Distress and sleep quality in breast cancer patients. Poster presentation at 
the annual Research!Louisville conference, Louisville, KY.  
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4. Fields, O., Cash, E., Zimmaro, L.A., Hicks, A., Albert, C., Sephton, S.E. (2016, 
July). Rest-activity rhythms and quality of life in lung cancer patients. Poster 
presentation at the National Cancer Institute/ R25 Cancer Research Program 
Presentation Day, Louisville, KY. 
 
______________________________________________________________________________ 
LABORATORY AND DATA ANALYTIC SKILLS       
 
fMRI  
Experience in independently operating GE 3T fMRI scanner. Experience utilizing Linux OS, and 
fMRI preprocessing and individual and group analysis through SPM2-8, FSL, and TORTOISE.  
 
Endocrinology 
Experience in collecting, preparing, processing, and preserving human saliva samples. Proficient 
in cortisol data cleaning and reduction. 
 
Immunology 
Experience processing and preserving serum and plasma human blood samples. Experience 
preparing under sterile technique and preserving human whole blood samples for stimulated 
immunomodulator analysis.  
 
Circadian Rhythms 
Experience in initializing and downloading MicroMini Motionlogger Actiwatches.  
 
Data Analysis 
Experience in conducting univariate and multivariate analyses, structural equation modeling, 
survival analyses. Experience using the following statistical software: SPSS, AMOS. Experience 
in REDCap data capture system. 
 
______________________________________________________________________________ 
HONORS, AWARDS, & SCHOLARSHIPS        
 
Oct. 2016 Yoga Teacher Training Scholarship Recipient  
  Kentucky Yoga Initiative, Louisville, KY   
 
July 2015 “Best Student Poster” Award 
  World Congress on Psycho-Oncology, Washington, DC 
   
May 2015  Excellence in Research Award  
  University of Louisville, Department of Psychological and Brain Sciences 
 
March 2015 Research Presentation Selected for Press Release (Zimmaro et al., 2015) 
  American Psychosomatic Society, Savannah, GA 
 
March 2014 Student Spotlight Award 
University of Louisville, School of Interdisciplinary and Graduate Studies 
 
July 2013 UofL SIGS Doctoral Research Fellowship Recipient 
University of Louisville, School of Interdisciplinary and Graduate Studies 
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April 2011  First Place winner, Clinical Research Abstract: Trainee category. (Zimmaro et 
  al., 2011) 
  Children’s National Medical Center Research Day, Washington, DC 
 
April 2011  First Place winner, Clinical Research Abstract: Post-Doc category. (Sepeta, 
Zimmaro, et al., 2011) 
Children’s National Medical Center Research Day, Washington, DC 
 
May 2010 Magna Cum Laude 
Wake Forest University 
 
April 2010  Psi Chi Psychology Honor Society	  
Wake Forest University 
March 2010 Phi Beta Kappa Honor Society  
Wake Forest University 
                          
May 2009 Undergraduate Research Fellowship Recipient 
  Wake Forest University, Department of Biology 
       
2009, 2014 Golden Key International Honour Society 
  Wake Forest University (2009); University of Louisville (2014) 
 
2006 - 2010  Dean’s List 




PROFESSIONAL EXPERIENCE AND MEMBERSHIPS      	  
  
2016    Ad-Hoc Peer Reviewer (Journal of Health Psychology, 
Mindfulness)                    
May 2015 – Present   Student Member:  International Positive Psychology 
Association, Health Division 
 
July 2014 – Present  Student Member:  American Psychosomatic Society  
     
  
______________________________________________________________________________
ACADEMIC TEACHING EXPERIENCE          	  
 
Nov. 2014   University of Louisville 
College of the Arts and Sciences 
Role: Contributing Member for Workshop	  
Salmon, P.G., Altman, J., Bayley-Veloso, R., Cash, E., 
Ellsworth, M., Phillips, K., Rebholz, W., Sephton, S., Zimmaro, 
L.A. (November 1, 2014) A Day of Mindfulness, Workshop for 
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the University of Louisville Alumni Association, College of Arts 
and Sciences. 
 
Sept. 2014    University of Louisville  
College of the Arts and Sciences, School of Social Work 
Role: Guest Co-Lecturer with Paul Salmon, PhD 
Salmon, P., Zimmaro L.A. (September 9, 2014). Mindfulness 
and Cancer, Guest Lecture for Course Entitled ‘Psychosocial 
Oncology’   
 
______________________________________________________________________________
VOLUNTEER ACTIVITIES         	  
 
April 2016 – June 2017 Kentucky Yoga Initiative, Louisville, KY 
    Role: Volunteer Yoga Instructor  
 
Independently lead weekly yoga classes for non-English-
speaking elderly refugees in Louisville area. Create sequence of 
chair and standing yoga positions. Classes are in  collaboration 
with Kentucky Refugees Ministries. Class attendance ranges 
from 12-20 refugees per class. Other involvement includes 
questionnaire development for outcome research of all yoga 
classes provided around the city.  
 
 
May 2015 – Nov. 2016  502 Power Yoga, Louisville, KY    
    Role:  Energy Exchange Team Member  
 
    Volunteer 3 hours each week to aid in administrative functions 
of local yoga studio. 
 
 
Sept. 2014    Zion Baptist Church Health Fair, Louisville, KY 
    Role: University of Louisville Psychological Services Center 
    Representative 
 
Volunteered as a University of Louisville Psychological Services 
Center representative from the mindfulness clinical team. 
Discussed brief mindfulness-based techniques to reduce stress 
with community members. 
 
 
May 2012 – June 2013  Yoga District Studios, Washington, DC 
Role: Volunteer Intern   
                       
    Participated in launching programs and events promoting 
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accessibility to mindfulness and fitness techniques through yoga. 
Volunteered aiding in administrative functions of the yoga studio 
once a week. 
 
 
March 2011 – June 2013 Yoga Activist, Washington, DC 
Role: Volunteer Understudy Yoga Instructor 
        
    Co-led yoga classes to groups of homeless men and women from 
shelters and recovery programs around the Washington, DC area. 
Create sequence of chair and standing yoga positions. Classes 
were in collaboration with “Back On My Feet” program and 
various local homeless shelters. 
 
______________________________________________________________________________
LEADERSHIP ACTIVITIES         	  
 
July 2009 – May 2010   Embassy of Australia, Washington, DC 
Australian Education International 
Role: Student Ambassador                                                                                                                       
 
Selected to serve by Embassy of Australia, University of 
Sydney, and Wake Forest University. Planned, marketed, and 
implemented four events at Wake Forest University to promote 
studying in Australia for study abroad and exchange, 
undergraduate and graduate education. Communicated 
frequently with Embassy of Australia, University of Sydney, and 
Wake Forest University’s Study Abroad office. 
 
 
Jan. 2009 – May 2010  Arcadia University Study Abroad Program, Glenside, PA 
Role: Student Advisor  
 
    Advised potential study abroad students and helped prepare 
students for education abroad. 
 
      
Aug. 2009 – Jan. 2010  Wake Forest University, Delta Delta Delta Sorority 
Role: Panhellenic Recruitment Counselor  
 
    Advised and counseled potential new Greek organization 
    members who were participating in recruitment. 
 
 
Jan. 2008 – May 2008   Wake Forest University Student Government 
Role:  Co-chair, Campus Life Committee   
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Co-led team of 10 student government members on issues of 
campus interest. Delegated tasks to members, facilitated weekly 
meetings, and collaborated with multiple campus activity groups. 
 
 
Aug. 2007 – May 2008   Wake Forest University Student Government 
Role: Chair, Springfest Carnival Committee  
 
    Created and allocated $24,000 budget; negotiated services, 
pricing, and approved contracts with food and entertainment 
vendors. Planned and implemented annual campus-wide event, 
oversaw committee activities, and delegated duties for 10. 
 
 
Aug. 2007 – May 2008   Wake Forest University Student Government 
Role: Co-chair, Executive Advisory Committee on 
Sustainability  
     
    Co-coordinated forum of 50 to discuss campus-wide 
environmental issues. Collaborated with other environmental 
awareness groups on campus.  
 
 
 
	  
	  
	  
	  	  
